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Purification and Immobilisation of Uricase for Use 
in Automated Analysis
by Abu Bakar bin Salleh
A procedure for the purification of uricase from 
porcine liver is described, utilising the technique 
of bioaffinity chromatography as a major purification 
step. Bioaffinity support is prepared by coupling of 
urate to bisoxirane-activated Sepharose 4B, Purified 
uricase shows a single protein band corresponding to 
the activity band, when applied to polyacrylamide disc- 
gel electrophoresis. A single protein band but no 
activity band is obtained by SDS-acrylamide disc-gel 
electrophoresis. The enzyme has a pH optimum in the
range of 8,9-9.1, with a V of 12.6 U.mg ^ , a K ofr IT19.5C ^  rn1 X 10 M and a molecular weight of 13 x 10 . Each 
enzyme molecule comprises 4 subunits of molecular weight 
32-34 X 10^ each. Nylon tube is directly activated by 
alkaline glutaraldehyde solution to generate reactive 
centres for enzyme immobilisation. The optimal con­
ditions for activation are studied. Purified uricase 
is immobilised to PEI-glutaraldehyde-nylon tube with 
about 20% activity retention. The derivatised enzyme 
has a pH optimum in the range of 9.0-9.2 and a of 
about 4 times that of the soluble enzyme. Immobilised 
uricase is incorporated into a continuous flow Auto- 
Analyser for use in the automated analysis of serum 
urate. For this purpose, the immobilised enzyme shows 
good storage and operational stability. Linear 
calibration plots can be obtained for a urate range of 
2 - 2 0  mg.lOOml ^, the method exhibiting a high degree 
of precision and accuracy. The results obtained also 
compare favourably with an established method of urate 
assay which employs soluble uricase.
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1. INTRODUCTION
1.1 Uric Acid in serum and methods for determination of its levels
Uricase, also known as urate oxidase (urate:oxygen 
oxidoreductase, EC 1*7»3*3) is responsible for the oxidative 
scission of the purine ring. It is of great importance to all 
organisms that do not excrete uric acid or some other purine. It 
is generally accepted that all mammals except man and the higher 
apes possess uricase (1 ).
Due to the absence of uricase, man excretes uric acid as the 
final product of purine catabolism. Thus a level of urate is
naturally maintained in the blood. Orowan (2) suggested that
the presence of urate in the blood has contributed in the evolution 
of man as an intellectual animal. Urate, like other purines 
such as caffeine and theobromine, may have acted as a cerebral 
stimulant, and the constant pressure of stimulation may have 
promoted cerebral development. It is believed that there may 
have been a gradual elimination of uricase during evolution.
Studies in some species of Old World monkeys showed the presence 
of highly unstable uricase, unlike that of prosimians and rabbits, 
which perhaps reflected a partial degeneration of the enzyme 
in these species (3).
On the other hand the loss of uricase may be considered 
as an unfortunate occurrence during evolution of man and it is 
held responsible for the occurrence of hyperuricaemia and related 
diseases.
Hyperuricaemia is rather difficult to define as it depends 
on what is considered as the normal level of urate in serum.
Studies of different population samples have shown that the mean 
values of the levels of urate in serum vary with age, sex, 
environmental, ethnic and anthromorphic differences (4). A 
typical study of a healthy population showed the urate levels 
in serum to be 5.1 ± 0.8 mg uric acid. 100 ml"*^ in men and
4.1 ± 0.7 mg uric acid.100 ml~^ in women (5). Values of serum 
urate greater than 7 mg.100 ml”  ^ in men and 5 mg uric acid.100 ml”  ^
in women are chosen as the arbitrary values to define hyperuricaemia, 
based on epidemiological surveys (6 ). Peters and Van Slyke (7) 
considered 6.4 mg uric acid.100 ml”  ^as the upper limit of 'normal' 
level of urate in serum. At this concentration, the serum is 
saturated with monosodium urate and urate crystals may precipitate.
The relative insolubility of uric acid and the absence of 
uricase to degrade uric acid to the more soluble compound, 
allantoin, gives rise to a disease known as gout. The accumulation 
of urate above the normal level in serum may lead to the typical 
gout syndrome, such as recurrent attacks of acute arthritis, 
formation of tophaceous deposits of monosodium urate within joint 
tissues and production of stones in the kidneys.
Primary gout is a genetically determined disorder of purine 
metabolism found in men. There are some rare occurrences in 
women usually found in post-menopausal individuals. It seems 
that sex differences in the levels of urate in serum disappear 
with age, and apparently metabolic and hormonal factors are 
involved.
Primary gout may be due to the increased production of uric 
acid brought about by increased purine biosynthesis de novo, 
increased catabolism of nucleic acids or ingestion of excessive 
purine diet. Decreased excretion of uric acid caused by 
decreased renal clearance also contributes to the increase in 
serum urate levels. These factors may act singly but more 
often all at once in contributing to the hyperuricaemic state 
and gout.
Secondary gout is an acquired form of the disease. Gouty 
arthritis is developed as a complication of hyperuricaemia 
caused by disorders such as leukemia, uronic nephritis and 
polycythaemia. These types of diseases are usually due to 
high urate levels caused by abnormally rapid turnover of nucleic 
acids.
Gout has been known for centuries and the disease described 
in ancient literature (8 ). More up to date and detailed 
treatises are available (4,5,9).
A unique form of secondary gout may be found in children 
and adolescents but its occurrence is very rare. However, 
another disorder attributed to excessive production of uric acid, 
affecting children only, is the Lesch-Nyhan syndrome (10,11).
This disease is an X-linked disorder and thus affects men only. 
The syndrome is characterised by muscle spasticity, mental 
retardation and compulsion for self-mutilation. The first sign 
of abnormality, delay in motor development, can be observed as
early as four months after birth, and this disorder usually 
leads to death before puberty.
The Lesch-Nyhan syndrome is attributed to a deficiency 
in a particular enzyme in the purine biosynthetic pathway, 
hypoxanthine-guanine phosphoribosyl transferase (HPRT)
(IMP: pyrophosphate phosphoribosyl transferase, EC 2.4.2.8 )
(12). Fig. 1.1.1 shows the biosynthetic pathway of purines 
and its feedback control. Purine nucleotides and their pyro­
phosphates normally serve to inhibit 5-phosphoribosyl-l- 
pyrophosphate (PRPP)-glutamine amidotransferase (ribosylamine- 
5-phosphate : pyrophosphate phosphoribosyl transferase 
(glutamate amidating), EC 2.4.2.14), the rate limiting enzyme 
in the pathway. HPRT, the enzyme deficient in the Lesch- 
Nyhan syndrome shares the same substrate as the PRPP-glutamine 
amidotransferase. The absence of HPRT, results in the 
accumulation of PRPP. Increased PRPP concentration is found in 
children suffering from this disease and it appears to contribute 
to excessive purine synthesis.
Restriction of purines, proteins, alcohols and caloric 
intake has been used to regulate urate levels in serum. Influences 
upon both the rate of production and excretion of urate have been 
cited, but the full role of their complex inter-relationship 
is not known. Thus dietary therapy is no longer recognised as 
an acceptable treatment.
PRPP
+ glutamine
PRPP-glutamine amidotransferase
Ifeedback 5-phosphoribosylamine feedback
inhibition
It1Nucleic 11
acid I - - - -
& inhibitionIntermediate
reactions
Guanylic acidi!4 I
Nucleic
acid
Guano sine HPRT
Inosihic acid^-
Inosine^
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Guanine £ j Hypoxanthine
PRPP PRPP
Xanthine oxidase
Xanthine
Adenylic acid
Adenosine
Adenine
PRPP
Xanthine oxidase
Uric acid
Fig. 1.1.1 Feedback control of purine biosynthesis.
Colchicine is commonly used for treatment of acute gout.
The mechanism of action is uncertain but it does relieve the 
pain of arthritic attacks. Other drugs such as phenylbutazone, 
oxyphenbutazone and indomethacine are available for use in the 
therapy of acute gout (13).
Hypouricaemic drugs provide the definitive method for 
controlling the disorders associated with gout (14). Uricosuric 
drugs such as probenecid and sulphinpyrazone have been widely 
used, while combined action drugs such as halofenate, a hypo- 
lipidaemic and uricosuric drug, and ticrynafen, a diuretic 
urico-suric drug, have found limited acceptance.
Allopurinol has been used extensively to decrease uric acid 
synthesis. Fig. 1.1.2 shows its possible mechanism of action.
It is worth noting that since step 1, 2 and 3 the rate inhibition 
steps are dependent on HRPT, allopurinol has no effect in 
decreasing de novo synthesis of purines in patients suffering 
the Lesch-Nyhan syndrome, resulting in striking increase in 
excretion of hypoxanthine and xanthine which roughly equals the 
decrease in uric acid formation.
Infusion of soluble uricase has been shown to bring about 
a decrease in serum urate levels (15-17). However, this method 
is ineffective mainly due to the formation of antibody against 
the enzyme. The use of immobilised uricase for this purpose 
is very much in the experimental stage (18,19).
PRPP + Glutamine
Phosphoribosylamine
Inosinic Allopurinol
acid ribonucleotide
PP PP
PRPP ^ PRPP
Hypoxanthine Allopurinol
Inhibition
Xanthine
Uric acid
Fig. 1.1.2 Possible mechanism of allopurinol action in 
inhibition of purine synthesis and lowering of urate levels
in serum.
Unfortunately in the case of the Lesch-Nyhan syndrome, the 
lowering of urate levels in serum is not sufficient in halting 
damage to the nervous system and mental retardation even though 
the disorder is discovered in the initial stages. No cure has 
been discovered to combat this disorder effectively (4).
Many methods for determining urate levels in biological 
fluids havé been developed for use in diagnostic purposes and 
monitoring therapy (20). Traditional methods are based on ’ 
either the reduction of phosphotungstate (2 1 ) or copper-complex 
(2 2 ) which are subject to interferance due to turbidity and 
non-urate reducing substances such as glucose, cysteine and 
ascorbic acid (23). Thus methods utilising uricase are generally 
recognised to be superior (24,25). Enzymatic methods utilising 
differential ultra-violet spectrophotometry have been developed, 
urate being maximally absorbed at 290-293nm (25-28). Alternatively 
hydrogen peroxide produced by the uricase catalysed reaction can 
be measured, as shown by the method of Kageyama (29).
Uric Acid + 2H 2O + O 2  allantoin + CO2 + H 2P 2
H 2O 2 + CH3OH + 2H 2O
HCHO + acetylacetone + (NH]^ ) -------- ►-3,5-diacetyl-l, 4-dihydrolutidine
+ 3H2P
Hydrogen peroxide reduced in the presence of catalase 
(H2O 2 ÎH2O 2 oxidoreductase, EC 1.11.1.6) is coupled to a 
condensation reaction which yields a colour product determined 
at 410nm.
Uricase-generated hydrogen peroxide can also be oxidatively 
couples to selected chromogens, catalysed by peroxidase 
(donor:H2Û 2 oxidoreductase, EC 1.11.1.7) to produce a colour 
product. The choice of the chromogens is also critical as some 
of the chromogens are affected by reducing compounds (30).
The use of chromogens can be avoided by linking to a 
third enzymic reaction. Catalase-generated aldehyde is reacted 
with NAD or NADH in the presence of aldehyde or alcohol 
dehydrogenase (aldehyde: NAD(P) oxidoreductase, EC 1.2.1.5 
or alcohol:NAD oxidoreductase, EC 1.1.1.1). The absorption 
of NADH or NAD is a measure of urate concentration (31,32).
H 2P 2 + ethanol _Ç&talase^^acetaldehyde + 2H 2O
(a) Acetaldehyde + NAD'*" —j. ^  acetate + NADH + H**"dehydrogenase
(b) Acetaldehyde + NADH + H"*" -deh^drogenase~^ ethanol + NAD+
Since the development of automated analysers (33), methods 
utilising this procedure are preferred due to their greater 
precision and speedier operation. The phosphotungstate method 
has been incorporated onto the AutoAnalyser (Technicon)(34) 
and Morgenstern (35) adopted the copper chelation method onto 
the AutoAnalyser and the Robot Chemist (Warner-Chillot Laboratories) 
Gochman and Smitz (30) developed a uricase-peroxidase method 
incorporated onto the -AutoAnalyser, and the method of Kageyama 
has also been adapted to an automated procedure (36).
%
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HacRae C37) automated a uricase method utilising urate 
absorption at 290nm.
The problems associated with the use phosphotungstate 
and copper chelation techniques in manual methods are still 
potentially present when these methods are adapted to 
automated procedures (23). Generally these methods give 
higher values of urate levels when compared with enzymatic 
methods (23,38,39).
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1.2 Purification of uricase
1.2.1 Methods for purification of uricase and some studies on 
the enzymic reaction of uricase
Uricase was first identified some seventy years ago by 
Batelli and Stern (40) . Since then there have been many attempts 
at isolating the enzyme and studying its properties.
Uricase has been isolated from various sources, including 
porcine liver (41-43), bovine kidney (44-46), rat liver (47), 
bacteria (48,49) and yeast (50). Baudhuin et (51) studied 
extensively the intracellular localisation of uricase in rat 
kidney and liver, and found that this enzyme was located in the 
cytoplasmic particles known as microbodies and peroxisomes.
Leighton et al. (52) and Tsukada et (53) clarified that uricase 
was in fact localised in the crystalloid core of the microbodies.
In many procedures (41-43), the initial stage was to obtain 
the mitochondrial fraction from neutral pH suspension, a step 
requiring high speed centrifugation. Leone (44) and London 
and Hudson (45) used alkaline extraction of uricase in the initial 
step. In fact the concept of extraction or precipitation of 
uricase in alkaline or acidic condition is adopted in many 
preparative procedures as exemplified by the method of Robbin 
et al.(54) .
Adsorption chromatography was used by some workers with 
calcium phosphate gels being the early choice (42,44,45). Later, 
the use of ionic exchangers was reported but the main result seemed
12
to be low recovery of enzyme activity (45,48-50).
Low enzyme recovery was also reported when tert-butanol 
was used as a precipitating agent (42,43,47).
Mahler (42) obtained an enzyme with specific activity of 
about 10 U.mg~^, but with recovery between 10-30%. Leone (45) 
achieved less than 30% recovery with uricase of specific activity 
of around 0.6 U.mg"^. Townsend and Lata (47) achieved nearly 
50% recovery with the specific activity of uricase of nearly 
10 U.mg~^, obtained from rat liver. On the other hand,
Yokota (41) only managed to recover 36% uricase activity from 
porcine liver, with specific activity of around 5 U.mg” .^
Baum et a2.(55,56) and Mahler (57) studied uricase purified 
from porcine liver, and showed evidence that the enzyme contained 
copper. Studies with models of copper-catalysed oxidation of 
urate, suggests that copper is an essential component of the 
catalytic site of uricase.
Uricase does not catalyse the conversion of urate directly 
to allantoin, carbon dioxide and water. Praetorius (58) and 
Mahler et al.(59) reported the appearance of transitory intermediates, 
and structure 1 has been proposed for one of these intermediates, 
l-carboxy-2,4,5,8 -tetraazabicyclo(3.3.0)octa-4-ene-3,7-dione.
13
The proposed structure assumes an oxidation by O 2 during 
the course of the enzyme catalysed reaction. Klemperer (60) 
suggested the CO 2 was released during the intermediate breakdown, 
and this has been substantiated by Pitts and Priest (61). Thus
it appears that urate is catalysed to an intermediate by uricase
(reaction 1). The decay of intermediate is independent of O 2 
and uricase, and the product can vary depending upon the absence
(reaction 2) or presence (reaction 3) of borate (62),
k urrcase O + O2  -------V
N
H COO-H 
N
H COO" H 
N
0  + H 2O 2
^  N '
H
reaction 1
H COO-H H «or
0 = /  T  % = o  > o
N
;o + HCO
N o
reaction 2
H COO*
N N-v A ^ H  NH2
0=^ I y  0 0= / I + 9=0
H
I 
INH^
alloxanate reaction 3
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In their investigation of steady state mechanism of uricase, 
Baum (56) proposed an ordered sequential binding of
substrate, oxygen and urate, based on the observation that the 
apparent and Vypqy are different in air and in 100% oxygen 
atmosphere. Recent studies however suggests random binding is 
more likely (63).
A
E
U
V  7EO2------ ^ —  EUO2
U
O2
EU
The scheme above was proposed by Pitts and Priest (63).
It depicts a single-site model for the uricase enzymic reaction. 
E designates the free or unbound enzyme, U designates urate. 
Reaction steps 2,4,6 and 8 are the reverse of reaction 1,3,5 and 
7. Steps 9 and 10 show irreversible reactions, however, there 
is no suggestion that these steps depicts the mechanism for 
product release.
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1.2.2 Bioaffinity chromatography
Bioaffinity chromatography e2q)loits a unique biological 
property of many proteins in their ability to bind ligands 
specifically and reversibly. Thus isolation of proteins by 
bioaffinity chromatography presents considerable advantages over 
conventional procedures for protein purification which are 
generally based on relatively small differences in physico­
chemical properties of the protein mixtures.
The principle of biospecific adsorption was initially 
used in the isolation and purification of antibodies with solid 
phase iramuno-adsorbents (64). Now its use is more widespread, 
and in principle this technique can also be applied to purify 
enzymes, nucleic acids, hormones or hormone receptors and 
drugs (65-68).
Successful application of this technique depends largely 
on the choice of support matrix and ligand specificity, the means 
of linkage between ligand and support, and the conditions used 
for adsorption and elution.
An ideal support matrix for bioaffinity chromatography of 
enzyme must have low interaction with proteins in general to 
minimise non-specific adsorption of proteins. It must possess 
good flow properties that can be retained even after ligand 
coupling, and naturally the integrity of the matrix must be 
maintained during chemical activation and coupling to a variety 
of ligands. Furthermore, it should possess wide stability
16
spectrum mechanically and chemically to the various conditions 
of pH, ionic strength, temperature, or the presence of dénaturants 
which may be utilised in the chromatographic process.
Cuatrecasas (69) discussed in detail the merit of many 
insoluble supports, and concluded that the beaded derivatives 
of agarose, a polysaccharide polymer, was ideal in many ways for 
use as an affinity support.
The small molecule chosen for attachment to the support 
must display specific affinity for the macromolecule to be 
purified. It can be an inhibitor, a cofactor or in some cases 
a substrate. The small molecule must possess chemical groups 
that can be modified for linkage to the support.
The affinity of enzyme for the ligand can be affected by 
steric hindrance if the ligand is attached in close proximity J
to the support. To overcome possible steric hindrance, ligand 
is attached at a distance from the support by introducing a 
spacer molecule between the ligand and support (69) . Long 
hydrocarbon chains can be used as the spacer molecule between 
the support and ligand, either by preparing the ligand with the 
spacer molecule attached before coupling to the support, or the 
spacer is attached to the activated support before linkage of 
the ligand.
Methods for chemical activation of various supports and 
coupling of ligands for use in a number of bioaffinity systems 
have been extensively reviewed (69-71), Agarose itself can be
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activated in many ways. The most commonly used procedure is 
its activation by cyanogen bromide (72).
The use of long chain bifunctional reagents such as bisoxiranes 
or divinylsulfone avoids the necessity of introducing a spacer 
molecule between the ligand and support (73).
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1.3 Immobilised enzymes
1.3.1 General aspects of immobilised enzymes
A general definition for the immobilisation of an enzyme 
is the physical entrapment or localisation of the enzyme molecule 
during a continuous catalytic process. It has been recommended 
that the term 'immobilised enzyme' should be used to describe 
all enzyme preparations in which the enzyme is constrained one 
way or another within the limited confines of the supporting 
polymer (74).
Great attention has been focused on the isolation of pure 
and soluble enzymes that there is a tendency to forget that most 
enzymes in vi-vo are either attached to membranes or embedded 
in a viscous environment. Immobilised enzymes offer the opportunity 
of studying enzyme systems which may closely resemble enzyme 
systems in V'Cvo, A clearer and truer picture of enzyme structure 
and catalysis could be then visualised. Studies in these 
directions were discussed by Brown (75) and Mosbach (76).
However, studies of immobilised enzymes may have been 
inspired by the possibilities of using these enzyme derivatives 
in many practical applications. Immobilised enzymes are being 
used in the field of medicine, clinical analysis, food and the 
pharmaceutical industries, and a large proportion of research 
is channeled towards these purposes (77-79).
There are many methods developed for enzyme immobilisation, 
and excellent reviews have been written on this topic (65,78,80).
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Enzymes can be directly adsorped onto insoluble support as 
illustrated by Nelson and Griffin (81) who used charcoal and 
aluminium hydroxide for adsorption of g-fructofuranosidase 
(8-D-fructofuranoside fructohydrolase, EC 3.2,1.26). This 
technique has limited use as the enzymes are liable to desorption 
by changes in pH, ionic strength and temperature of assay 
systCTis (82). Alternative methods such as gel entrapment as 
adopted by Hick and Updike (83) for immobilisation of D-amino 
acid oxidase (D-amino acid : oxygen oxidoreductase, EC 1.4.3-.3) 
in polyacrylamide gel, and microencapsulation technique as used 
by Chang and Poznansky (84) for encapsulation of catalase in 
collodoin membrane, generally require no chemical modification 
of the enzymes. These methods results in fairly high enzyme 
activity retention but are subject to enzyme leakage during 
usage.
Probably the best method for enzyme immobilisation is by 
covalent attachment of enzymes to insoluble supports (65).
This technique involves chemically coupling the enzyme molecule to 
a support through its free amino, carboxyl, hydroxyl, sulphydryl, 
phenol or imidazole groups. As there are multiple duplications 
of these groups in each enzyme molecule, there may be partial 
loss of activity on immobilisation, assuming some of the groups 
used in the coupling are catalytically essential.
There appears to be no way of predicting the activity of an 
enzyme on immobilisation. Retention of activity depends on 
many factors and are peculiar for each particular enzyme. Each 
enzyme must be treated in isolation and immobilised in a manner 
suitable to that enzyme and its proposed use.
4
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When an enzyme is immobilised to an insoluble support, or 
entrapped within a lattice structure, restrictions are imposed 
on the enzyme molecules often leading to changes in its physical 
and conformational properties. There is generally a lowering 
of activity when an enzyme is immobilised. The decrease in 
activity may be due to the destruction of some of the enzyme 
molecules or partial reduction of all bound enzymes or more 
likely the combination of both. Loss in activity may be 
attributed to the use of certain side chains from the active 
sites during the coupling process. Certain side chains used 
in the covalent linkage may be essential for the tertiary 
conformation of the enzyme molecule. The tertiary conformation 
may also be disrupted by interaction with hydrophobic supports 
and strains from covalent linkage. Conversely there can be 
enhanced stability to dénaturants, proteolytic and thermal 
activation (.65,77,80) .
The effect of ionic support may cause a shift in the pH 
profile of the enzymes. Enzyme bound to positively charged 
matrix was shown to have its pH profile shifted to the left 
(.acidic) , whereas enzyme bound to negatively charged support 
has its pH profile shifted to the right (alkaline) (80).
These shifts may be due to the microenvironmental effect where 
there may be greater or lesser 'local concentration’ of hydrogen 
ions then in the bulk solution when the matrix is negatively 
or positively charged respectively.
Diffusional effect is also prominent in immobilised enzyme 
systems. The enzyme particles may be covered by an unstirred
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layer which affects the diffusion of substrates or products in the 
vicinity of the immobilised enzyme molecule (85,86).
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1.3.2 Immobilisation of enzymes onto nylon, and their use in 
automated analysis
Nylon is an unbranched polymer containing secondary amide, 
typically synthesised by condensing a h-is aliphatic amine with 
a h'ls aliphatic carboxylic acid. Nylon 6 is the polymerisation 
product of caprolactam, and has a single repeating 6-carbon unit 
of five methylene and an amide group. Nylon 66 on the other 
hand is the polycondensation product of adipic acid with 
hexamethylene diamine, giving a polymer of alternate 6-carbon 
unit of four and six methylene units respectively.
Nylon polymer makes ideal support matrices for enzyme 
immobilisation. It is mechanically strong, resistant to 
microbial attack, and it is available at moderate cost in 
different forms of mesh, powder, membrane and tube.
High molecular weight nylon polymer has few free amino 
or carboxyl groups, but the secondary amide groups are 
potentially reactive. Secondary amide groups can be cleaved 
hydrolytically under acidic condition to yield free amine or 
carboxylic groups (87), or non-hydrolytically with an amine 
such as N,N-dimethyl-l,3-propane diamine under non-aqueous 
condition (88).
Hydrolysis may cause the loss of structural integrity of 
the nylon polymer. Goldstein e^ al.(89) generated reactive 
centres by N-substitution of secondary amide involving mild
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acid hydrolysis followed by a four components condensation 
reaction between amine, carboxyl, aldehyde and isocyanide which 
resulted in the restoration of intact nylon backbone.
Campbell et al.(90) 0-alkylated nylon with dimethyl 
sulphate at 100° for 3 min. However this method is rather 
harsh and difficult to control. Milder conditions were described 
by Morris et a^. (91) using triethyloxonium salt, a procedure 
optimised by Noy (92).
Introduction of a bifunctional amines or hydrazides between
the polymer and the enzyme molecule was found to produce higher
activity immobilised enzymes (90).
The coupling of enzymes to the activated nylon tube can be
achieved by the bisimidate or more frequently by the glutaraldehyde 
reaction.
The coupling of enzymes through bisimidates is brought about 
by the well characterised reactions of free amino groups with 
imidates to form amidines (93).
There is some doubt about the exact mechanism of glutaraldehyde 
action. It is found to be very reactive to the N-terminal amino 
acid, the sulphydryl group of cysteine and there is partial 
reactivity with the imidazole group of histidine (94). Studies 
on glutaraldehyde solution shows that it comprises primarily 
cyclic forms of hemihydrate (71%) whereas there is only a minor
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fraction of the linear form (4%) at 23° (95,96) . Korn ek 
(97) attributed the reactivity of glutaraldehyde to the free 
linear form, but Whipple and Ruta (96) proposed that the 
prominent role was contributed by the hemiacetal form.
Monsan at a^. (98) using NMR and IR spectroscopy found a 
polymerised form of glutaraldehyde as the stable form of the 
compound in alkaline solution. This polyglutaraldehyde is 
similar in structure to the one porposed by Richard and Knowles 
(99), but these groups of workers differ in their interpretation 
of the reaction mechanism. The latter hypothesised a Michael- 
type of reaction, whereas the former proposed a mechanism in 
which the aldehyde group appeared to be more reactive than the 
ethylenic group in the polymer (Pig. 1.3.2.1).
The advantages offered by using immobilised enzymes in 
analysis was discussed by H o m b y  and Noy (100) . Immobilised 
enzymes can be reused after each analysis. In the batch mode 
application, the immobilised enzymes can be retrieved either by 
filtration or centrifugation, or in the flow through mode, 
substrates or samples of analyte can be perfused continuously 
through the immobilised enzyme reactors. Many immobilised 
enzyme derivatives possess greater operational and storage 
stability, important properties for analytical reagents. These 
two factors combine to a third factor, the 'convenience' factor 
in the use of these enzyme derivatives.
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polyglutaraldehyde
CHO CHO
CHO - (CH2 ) 3 - CH = C - (CH2 ) 2 - CH = C - (CH2)2 - CHO
n
1 Enzyme-NH2
CHO * 1 CHO
CHO - (CH2 ) 3 “ CH - C - (CH2 ) 2 - CH - C - (CH2)2 - CHO1 H 1 H
Enzyme-NH Enzyme-NH n
(a)
-
CH=N-Enzyme
1
CH=N-EnzymeiCHO - (CH2 ) 3 - CH = 1C - (CH2 ) 2 - CH = C - (CH2 ) 2 - CHO
(b) n
Fig. 1.3.2.1 Reactions of glutaraldehyde with the free amino 
acid group of an enzyme.
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Application of immobilised enzymes in analysis have been 
reviewed on several occasions (101,102).
Novel analytical hardware systems have been developed, 
especially to accomodate and capitalise on the properties of the 
immobilised enzymes. Such an approach is illustrated by the 
development of enzyme electrodes (103), enzyme thermistors (104) 
and continuous flow systems (105).
The other approach is the incorporation of immobilised 
enzymes onto existing analytical hardware (105), Several types 
of immobilised enzyme derivatives have been used in continuous 
flow analysers of the type developed by the Technicon Instrument 
Company. Immobilised enzymes reactors are incorporated into 
the continuous flow system, and discreet samples are automatically 
analysed and the results recorded.
Glucose oxidase (3-D-glucose : oxygen oxidoreductase,
EC 1.1.3.4) and urease (urea amidohydrolase, EC 3.5.1.5), have 
been immobilised by cross-linking in pores of nylon membrane, 
for use in the automated analysis of glucose and urea (87), 
small packed beds of nylon powder covalently bound with urease 
and uricase have been developed for use in the automated 
determination of urea and uric acid (106).
Open tubular enzyme reactors are found to be most suitable
for this kind of flow system. Glucose oxidase has been immobilised
to polystyrene tube (107), and aldehyde, alcohol and glucose
dehydrogenases (glucose dehydrogenase; 8-D-glucose : NAD(P) 
oxidoreductase, EC 1.1,1.47) have been covalently immobilised
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onto nylon tube and incorporated into automated analysers in 
the analysis of their respective substrates (92).
In this work, a new procedure for purifying uricase from 
porcine liver is presented, utilising bioaffinity chromatography 
techniques. Nylon tube is activated directly by glutaraldehyde 
and purified uricase is immobilised to the activated nylon tube 
for use in the automated analysis of uric acid in serum.
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2. MATERIALS
The chemicals listed below are used in the relevant sections 
of this thesis. Abbreviated names of suppliers are included. 
Unless otherwise specified, the chemicals listed are of 
laboratory grade.
Substrates and inhibitors
Cyanuric acid 
B-D-glucose 
Potassium oxonate 
Potassium urate 
Uric acid 
Xanthine
Aldrich
Sigma
Aldrich
Sigma
B.D.H.
Sigma
Enzymes and proteins
Bovine serum albumin 
Glucose oxidase, fungal origin 
Human serum albumin 
Myoglobulin
Peroxidase, Type 11, from horse radish 
Uricase, Type IV, from Candida utitis
Sigma
Boehringer
Sigma
Sigma
Sigma
Sigma
Chromatographic components
DEAE-cellulose (DE52) 
Sephadex G25 (fine) 
Sephadex G200 (superfine)
Whatman
Pharmacia
Pharmacia
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Electrophoresis components and staining agents
Acrylamide (electrophoresis grade) B.D.H.
3-Amino-9-ethylcarbazole Aldrich
Coomassie Blue R250 B.D.H.
N ,N-dimethyl formamide B.D.H.
2-Mercaptoethanol B.D.H.
N,N-methylene bisacrylamide (electrophoresis
grade) B.D.H.
Riboflavin Sigma
Sodium dodecyl sulphate (electrophoresis
grade) B.D.H.
5,6,7,8-tetrahydro-l-napthylamine Aldrich
N,N,N',N'-tetramethylethylenediamine B.D.H.
Support and coupling agents
Boron trifluoride diethyl etherate
1,4-Butanediol diglycidyl ether 
Dimethyl suberimidate 
Epichlorohydrin 
Glutaraldehyde, 25%(w/v)
Nylon 6 tube ( 1 mm, internal diameter) 
Sepharose 4B
Aldrich
Aldrich
Sigma
Aldrich
B.D.H.
Port ex
Pharmacia
Miscellaneous
Adipic hydrazide
4-Aminophenazone 
L-Ascorbic acid 
L-cysteine
Cambrian
B.D.H.
Fison
Sigma
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Dialysis tubing 
Diaminoethane
3,5-Dichloro-2“hydroxybenzene sulphonyl
chloride
Folin-Ciocalteau reagent 
L-Glutathione 
Kjeldahl(mercury) tablets 
Polyethyleneimine (polymin P)(50%,w/v) 
Potassium alumina silicate
(molecular seive, type 3A) 
Sulphuric acid, nitrogen free 
Wellcomtrol serums
Sci. Instr. 
B.D.G.
Aldrich
Sigma
Sigma
B.D.H.
B.D.H.)
B.D.H.
B.D.H.
Wellcome
Solvents
Methanol (B.D.H.) was distilled and dried over molecular 
sieve. Dichlro.methane (B.D.H.) and diethyl ether (B.D.H.) 
were distilled and stored over calcium hydride (B.D.H.).
All other reagents used were of reagent grade.
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3. GENERAL METHODS
3.1 Assay of soluble enzyme activity
3.1.1 Uricase
Uricase activity was assayed by the rate of oxygen consumption, 
as shown in the reaction below.
Uric Acid + O 2 + H 2O allantoin + CO2 + H 2O 2
A unit of uricase activity is defined as one ymole of 
oxygen consumed min"^.
Specific activity is defined as the units of uricase mg 
protein"^.
Reagents
1. O.IM Borate buffer, pH 8.6.
2. Substrate, 4.46mM urate.
75 mg uric acid and 60 mg lithium carbonate were dissolved 
in warm distilled water (60°). After cooling the solution 
was made up to 100 ml.
3. Uricase solution.
Procedure
Buffer (5 ml) and enzyme (lO-lOOyl) were equilibrated in the 
reaction chamber at 25°. The reaction was initiated by the
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addition of lOOyl substrate.
Oxygen was monitored by a Yellow Spring Model 53 Oxygen 
Monitor. This unit was attached to a Devices DC6 amplifier and 
a Kipp & Zonen DBS recorder.
Saturated oxygen in water was taken as 230yl.-€“ .^ To 
calibrate the instrument, saturated sodium dithionite was used 
for complete oxygen consumption.
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3.1,2 Glucose oxidase (GOD)
Glucose oxidase activity was determined by the rate of 
oxygen consumption, as shown below.
î-D-glucose + 0% + H 2O — > $-D-gluconolactone + H 2O 2
A unit of GOD activity is defined as one ymole of oxygen 
consumed min"^.
Specific activity is defined as unit of activity mg protein”^. 
Reagents
1. O.IM Phosphate buffer pH 7.0.
2. Substrate - 0.55M glucose.
10 g D-glucose was dissolved in phosphate buffer and 
made up to 100 ml. The solution was allowed to mutarotate 
for at least 24h. before use.
Procedure
4.0 ml of buffer and 1.0 ml of substrate were equilibrated 
in the reaction chamber at 25°. The reaction was initiated by 
the addition of 20-100yl GOD.
Oxygen consumption was monitored by the oxygen electrode 
as described in section 3.1.1.
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3.2 Methods for determination of proteins
3.2.1 Protein estimation by the Micro-Biuret method
This method developed by Itzhaki and Gill (108) was used 
for estimation of protein solution in the range of 0.2-2.0 mg. 
ml-1.
Reagents
1. Solution A; 0.21% (w/v) CuSOi,..5H 2O in 30% (w/v) NaOH.
2. Solution B: 30%(w/v) NaOH.
3. Protein standards. Bovine serum albumin.
Procedure
Al - 2 ml distilled water + 1 ml solution A.
A 2 - 2 ml protein solution + 1 ml solution A.
B% - 2 ml distilled water + 1 ml solution B.
B 2 - 2 ml protein solution + 1 ml solution B.
The solutions were thoroughly mixed and the absorbance at 
310nm were read after 5 min. Solution A 2 was read against 
solution Aj and solution B 2 was read against B% . The difference 
in the two readings. Absorbance A - Absorbance B was taken as 
the net absorbance.
Standard protein solutions in the range of 0.2-2.0 mg.ml"^ 
were similarly treated. A graph of net absorbance against 
protein concentration was plotted as shown in Pig. 3.2.1.1.
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Fig. 3.2.1.1 Standard curve for the determination of proteins
(section 3.2.1}.
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3.2.2 Protein estimation by the Folin-Lowry method
This method was developed by Lowry al. (109) involving 
the reaction of copper in alkaline solution and the reduction 
of Folin-Ciocalteau reagent. This method was used in estimating 
low concentration of protein solutions.
Reagents
1. Solution A: 2%(w/v) sodium carbonate in O.IM NaOH.
2. Solution B: 0.5%(w/v) CuSO^.SHzO in 1%(w/v) sodium tartrate.
3. Solution C: 50 ml of solution A was mixed with 1 ml
solution B.
4. Solution D: Folin-Ciocalteau reagent, diluted to IM
with distilled water.
5. Protein standards. Bovine serum albumin.
Procedure
0.5 ml protein solution was mixed with 3 ml solution C and 
allowed to stand at room temperature for 15 min. An aliquot of 
solution D CO.3 ml) was then added to the mixture and immediately 
shaken and allowed to react for a further 30 min. The absorbance 
was read at 500nm and 750nm against a blank containing no protein,
A calibration plot was prepared by assaying standard 
solutions in the range 25-200yg. ml”^. Fig, 3.2.2.1 shows the 
plot obtained.
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Fig. 3.2.2.1 Standard curves for the determination of proteins
[section 3.2.2). (□) indicates absorbance at SOOnm, and (■)
indicates absorbance at 750nm.
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3.3 Buffers
Buffers were prepared by weighing appropriate amount of 
acid or base and diluting in water and titrating the solution 
to the required pH,
Typically O.IM phosphate buffer pH 7.0 was prepared by 
weighing 13.6g KH 2PO4 and dissolving it in about 800 ml water.
The solution was titrated to pH 7.0 by 2M NaOH and made up to 
ll.
Other buffers used are listed below. Appropriate amount 
of the first component was weighed and dissolved in water and 
titrated with the second component.
1. Boric acid - NaOH.
2. Glycine - NaOH.
3. TRIS - HCl.
The pH of all buffers was checked before use with the 
Radiometer pH meter (Copenhagen). The instrument,was calibrated 
daily with reference buffers.
1
■i
!
Ï
;
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3.4 Dialysis
Dialysis tubing was prepared by boiling in lOmM EDTA for 
20 min and then washed thoroughly in distilled water. The 
tubing was washed with the dialysis buffer before use. 
Dialysis was carried out at 4°.
Dialysis tubing was stored in 0.1%(v/v) sodium aside 
at 4®.
3.5 Centrifugation
Low speed centrifugation (less than 2000 x Q) was carried 
out on the MSE Mistral 6L centrifuge using appropriate rotors. 
Centrifugation requiring 5000 x g or greater were carried out 
on the MSE High Speed 18.
All centrifugations were carried out at 4° unless otherwise 
specified.
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4. PURIFICATION OF URICASE FROM PORCINE LIVER
4.1 Methods
4.1.1 Preparation of liver homogenate
The use of alkaline buffer to extract uricase from 
microbodies was utilised by Yokota (43). Studies on the effect 
of detergent, ionic strength and pH for the extraction and 
solubilisation of uricase have been carried out (1 1 0 ,1 1 1 ).
Borate ions and EDTA appear to confer a stabilising effect on 
uricase (1 1 2 ).
Reagents
1. Porcine liver. It was acquired immediately after slaughter 
and cooled in ice. It was either used on the day or 
stored frozen at -2 0 °.
2. Buffers
a. O.IM borate, ImM EDTA, pH 10.
b. O.IM borate, ImM EDTA, pH 11.
c. O.IM borate, ImM EDTA, 1.5%(v/v) Triton XlOO, pH 10.
d. O.IM borate, ImM EDTA, 3%(v/v) n-butanol, pH 10.
e. O.IM borate, ImM EDTA, 3%(v/v) n-butanol, 1.5%(v/v) Triton
XlOO, pH 10.
Procedure
Porcine liver was cut into small pieces, and as much tendon 
and fatty tissues as possible were removed. To every 100 g. liver,
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250 ml buffer was added. The mixture was homogenised in a 
Waring blender for 1 min and the homogenate stirred for 2h at 4<
The homogenate was diluted with 2 volumes of buffer, and 
stirred for a further 30 min. The homogenate was filtered 
through double layer muslin cloth.
For the purpose of monitoring the protein content, the 
homogenate was centrifuged at 5000 k g for 30 min and the 
supernatant assayed for protein (section 3.2.1).
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4.1.2 Heat treatment of homogenate
This is a common procedure adopted mainly for removal of 
some proteins, particularly enzymes of low thermal stability.
Procedure
Liver homogenate was placed in a conical flask, and the 
flask was immersed in an 80° bath. The homogenate was swirled 
around in the flask until the temperature of the homogenate 
reached 60°. The flask was immediately removed from the bath 
and stood at room temperature (ca. 20°) for 5 min. The 
temperature of the homogenate should stay in the range of 55-60° 
within this period. The temperature of the homogenate was 
then quickly brought down to under 1 0 ° by immersing the flask 
in an ice bath.
To assay for protein the treated homogenate was centrifuged 
at 5000 X g for 30 min and the supernatant assayed for protein 
by the micro-Biuret method (section 3.1.2).
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4.1.3 n-Butanol separation
This is a two-phase separation procedure as discussed by 
Morton (113) and is regarded as a general purification procedure.
Procedure
n-Butanol was chilled at -20° before use. Cold n-Butanol 
was slowly added to heat treated homogenate with stirring.
An over-head stirrer was necessary as the suspension got 
heavier with precipitation with addition of alcohol. The 
suspension was stirred for 15 rain after complete addition of the 
n-butanol (1 :1 ,v/v).
The suspension was centrifuged at 2000 x g for 60 min. The 
suspension was separated into three layers, an upper butanol 
layer, a middle butanol saturated residue and an aqueous layer 
containing uricase activity. The two upper layers were discarded,
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4.1.4 Ammonium sulphate precipitation
This is a general procedure adopted for concentration of 
the protein extract with some measure of purification.
Procedure
Ammonium sulphate crystals were finely grounded and 
dissolved in a protein extract obtained as described in 
section 4.1.3. Small fractions of ammonium sulphate were 
added at a time with constant stirring allowing the salt to 
dissolve and thus minimising high local concentration of salt 
in the solution. The solution was kept cool in an ice bath.
On complete addition of ammonium sulphate, the suspension 
was allowed to stand for at least Ih. The suspension was 
centrifuged at 5000 x g for 30 min. The precipitate was 
separated at the top of the centrifuged tube and harvested.
The supernatant was discarded.
The precipitates were mixed with O.IM borate, ImM EDTA 
pH 10.0 and stirred for 30 min. The suspension was centrifuged 
at 5000 X g for 30 min and the supernatant collected. The 
residue was re-extracted if necessary and the supernatant 
collected after centrifugation.
The supernatant which contained uricase activity was stored 
at - 2 0 °, when not required for immediate use.
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4.1.5 Ion exchange chromatography on DEAE-Cellulose
As this is one of the most regularly used purification 
techniques, its applicability in the purification of uricase 
was studied.
Procedure
DEAE-cellulose was prepared according to the instruction 
of the manufacturer (Improved Technique with Advanced Ion 
Exchange Cellulose-Whatman).
The ion-exchanger was packed in a column (1 x 12 cm) to a 
height of 10 cm. The DEAE-cellulose was equilibrated with 
lOmM borate, pH 8.5.
Uricase extract from ammonium sulphate precipitation 
(section 4.1.4) was dialysed in equilibrating buffer for 15h.
The dialysed sample was passed through the column at the rate 
of 0,5 m l . m i n " T h e  ion-exchanger was washed with the 
equilibrating buffer and a salt gradient of ammonium sulphate 
(0-0.25M, 160 ml) was passed through the column.
Fractions were assayed for uricase and protein was monitored 
at 280nm.
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4.1.6 Bioaffinity chromatography
4.1.6.1 Preparation of affinity support
a. Activation of sepharose 4B
The method used was developed by Sunberg and Porath (114) 
The reaction is shown below.
P - OH + CH2 - CH - CH2 - CH2 - O - (CH^)^ - O - CH 2 - CH - CH2 
Sepharose 1,4-butanediol diglycidyl ether.
P - O - CH2 - CH - CH2 - O - (CH2 )i+ - O - CH2 - CH - CH2I \  ^OH O"^
Procedure
50 g suction-dried Sepharose 4B was washed with it of 
distilled water. The gel was mixed with 50 ml 0.6M NaOH 
containing 100 mg sodium borohydride and 50 ml of 1,4-butanediol 
diglycidyl ether. The mixture was stirred for 8 h at 25°.
The activated gel was washed with at least it distilled 
water to remove excess 1,4-butanediol diglycidyl ether. The
activated gel was used immediately for ligand coupling.
b. Determination of oxirane groups attached to Sepharose 4B
Oxirane group reacts with sodium thiosulphate to produce 
sodium hydroxide as shown in the reaction below.
— CH — CH 2 t 2Na"^ + S 2O 3   > — CH — CH — S20g + 2Na"^ + OH
^ O  OH
oxirane
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Procedure
5 g. suction-dried activated Sepharose 4B was added to 
15 ml 1.3M sodium thiosulphate. The release of hydroxyl 
groups was monitored by titration against O.IM HCl. The amount 
of oxirane group g."l of gel was calculated by ymole of HCl 
required to keep the solution at neutrality.
i.e. the amount of oxirane groups attached g.“  ^ of Sepharose 4B,
volume of HCl x O.IM=  =------------ Umoleo
c. Coupling of ligands to the activated Sepharose 4B
The chemistry of binding of ligands to the activated gel 
is assumed to be similar to the activation of Sepharose 4B.
Reagents
1. Uric acid
0.25%, 0.5%, 1.0%(w/v) in water pH 12.
2. Xanthine
0.5, 1.0% (.w/v) in water pH 12,
3. Cyanuric acid
0.5, 1.0%(w/v) in water pH 12.
4. Oxonic acid, potassium salt 
1.0%(w/v) in water pH 12.
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Procedure
10 g of activated Sepharose 4B was mixed with 50 ml of 
ligand solution and the mixture stirred for 20 h at 25°.
The gel was washed with O.IM NaOH and distilled water. 
Appearance of urate in the wash was monitored at 293nm. Oxonate 
was monitored at 314nm, xanthine at 277nm and cyanurate at 
214nm. The gel was washed until no ligand was detected in the 
wash.
Unreacted oxirane group on the gel was removed by incubating 
the gel with IM N-ethanolamine overnight at 25°. The gel was 
washed with distilled water and stored in O.IM borate pH 9.0, 
containing 0.1%(w/v) sodium azide at 4°.
d. Determination of ligands coupled to Sepharose 4B
The amount of ligand attached to the gel was estimated by 
the determination of nitrogen content by the modified Kjeldahl 
method.
Reagents
1. Kjeldahl catalyst tablet. Each tablet contains 1 g 
sodium sulphate and 0 . 1  g mercury,
2. Alkaline solution. 60%(w/v) NaOH containing 5%(w/v) 
sodium thiosulphate.
3. Nitrogen free concentrated sulphuric acid.
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4. Borate buffer,
10 g boric acid was dissolved in about 700 ml distilled 
water and 2 0 0  ml absolute ethanol. 1 0  ml mixed indicator 
was added to the solution and it was adjusted to the required 
end point (grey) with O.IM NaOH. The volume was made up 
to 1-t with distilled water.
5. Mixed indicator.
33 mg Bromocresol green and 6 6  mg methyl red indicator 
were dissolved and made up to 1 0 0  ml in absolute ethanol.
6 . HCl, O.OIM.
Procedure
1 and 2 g suction dried Sepharose-ligand (as prepared in 
section 4.1.4.1c, obtained before incubation with N-ethanolamine) 
were dried at 100° over-night. Each sample was placed in a 
Kjeldahl flask and the digestion comprising half a tablet mercury 
catalyst, 2 ml nitrogen free concentrated sulphuric acid and 
2 anti-bump granules were added. The sample was digested for 3h 
and then allowed to cool at room temperature.
The mixture was transferred to the distillation apparatus, 
washed down twice with 3 ml distilled water. Ammonia was 
released from the mixture by adding 1 0 ml alkaline solution with 
steam distillation. The distillate was collected in a flask 
containing 5 ml borate buffer to a total volume of 50 ml.
The distillate was titrated against O.IM HCl.
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Sangles of uric acid (1 - 2 mg) were similarly treated and the 
recovery of nitrogen was estimated. Fig. 4.1.5.1.1. shows a 
plot of nitrogen recovery against digestion time.
4.1.6.2 Use of affinity support for uricase purification.
a. Capacity of affinity support
2 g suction-dried Sepharose-ligand was packed in a glass 
column ( 1 x 7  cm) and equilibrated with O.IM borate containing 
ImM EDTA pH 9.0,
A uricase sample as prepared in section 4.1.4 was dialysed 
in the equilibrating buffer for 16h. The sample was perfused 
through the affinity bed at a flow rate of 0.4 ml.min"
The column of affinity support was maintained at 4°.
The column effluent was monitored for uricase activity and 
protein content. The perfusion was terminated when the output 
sample activity was about 50% of the input activity.
b. Elution of uricase from affinity support
Eluants were passed through the affinity support packed in 
the column at the same rate as the adsorption procedure. Three 
different eluants were considered for elution of uricase from 
the affinity support.
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Fig. 4.1.6.1.1 Recovery of uric acid with period of digestion.
Nitrogen was determined by the Kjeldahl method (section 4.1.6.Id).
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1. Uric acid in O.IM borate buffer pH 9.0.
2. Xanthine in O.IM borate buffer pH 9.0.
3. Potassium oxonate in O.IM borate pH 9.0,
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4.1.7 Separation of inhibitors from uricase
Eluates from the affinity chromatography procedure were 
passed through Sephadex G25, to obtain the purified uricase.
Procedure
Sephadex G25 was prepared for use according to instruction 
of the manufacturer (Sephadex, Gel Filtration in Theory and 
Practice-Pharmacia). 30 g dry weight of Sephadex G25 was
allowed to swell in water for 3h at room temperature. The gel 
was packed onto a column (1.6 x 70 cm) up to a height of 60 cm. 
The columm was maintained at 4®.
The gel equilibrated with O.IM borate, pH 9.0.
A 4-10 ml saitple was applied to the column and the gel perfused 
with equilibrating buffer at the rate of 1 2 ml.min”
4 ml fractions of eluate were collected. Protein was 
monitored at 280nm, and active fractions were assayed for protein 
by the Folin-Lowry method (section 3.2.2).
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4.1.8 Concentration of uricase solution
Uricase solution was concentrated by filtration using the 
Centriflo-Membrane Ultrafilter (Amicon-Membrane Cone, 224-cf-50) 
This membrane has a cut-off molecular weight limit of 
50,000. Each membrane cone has a capacity of about 7 ml.
Filtration was achieved by centrifugation at 2000 x g.
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4.1.9 Gel filtration on Sephadex G20Q
This procedure is for separation of any other proteins 
which may have contaminated the uricase.
Procedure
Sephadex G200 was prepared for use according to the 
instruction of the manufacturer (Gel Filtration, Theory and 
Practice-Pharmacia). 5 g dry weight of the gel was allowed
to swell in water for 5h, incubated in a boiling water bath.
The gel was packed in a column (1.6 x 70 cm) to a height of 
60 cm, and equilibrated with O.IM borate buffer pH 9.0. The 
column was maintained at 4®.
Void volume was determined by applying 2 ml (2 mg.ml” ^) 
Dextran Blue, and measuring the elution volume.
5 ml sample from Sephadex G25 gel filtration (section 4.1.7) 
was applied to the column. The protein was eluted with the 
equilibrating buffer at the rate of 9 ml.rnin"^. All fractions 
collected were assayed for uricase activity and protein.
56
4.1.10 Polyacrylamide disc-gel electrophoresis
Two methods of polyacrylamide disc-gel electrophoresis 
were utilised for studying the purified uricase.
4.1.10.1 Polyacrylamide disc-gel electrophoresis by the method 
of Ornstein and Davis
This method followed the procedure put forward by Ornstein 
(115) and Davis (116). A slight modification was made in the 
order of gel preparation.
Reagents
Stock solutions.
A: IM HCl 48 ml
TRIS 36,6 g
TEMED 0.23 ml (pH 8.9)
Water to 1 0 0  ml
B: IM HCl 48 ml
TRIS 5.98 g
TEMED 0.46 ml (pH 6.7)
Water to 1 0 0  ml
C: Acrylaraide 28 g
BIS 0.735 g
Water to 1 0 0  ml
D: Acrylamide 1 0 g
BIS 2.5 g
Water to 1 0 0  ml
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E: Riboflavin 4 mg
Water to 100 ml
F: Sucrose 40 g
Water to 100 ml
The pH of the solution was adjusted by titration with 
IM HCl. Acrylamide solutions were filtered to remove debris.
Working solution.
Small pore gel
This solution was made of 1 part solution A, 2 parts 
solution C, 1 part water and 4 parts of 0.14%(w/v) ammonium 
persulphate solution. The pH was adjusted to pH 8.9.
Large pore solution
This solution was made of 1 part solution B, 2 parts of 
solution D, 1 part solution E and 4 parts solution F. The 
pH was adjusted to pH 6.7.
Stock buffer
This solution was made of 6 g TRIS, 28.8 g glycine and 
water to a total volume of iZ.. The pH was adjusted with IM HCl 
The stock buffer was diluted 1:10 for use during electrophoresis
Tracking dye
The tracking dye comprised 0.05%(w/v) Bromophenol Blue 
in water.
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Staining solution
The solution was made of 1.25 g Coomassie 250R in 454 ml
50% (v/v) methanol in water and 46 ml glacial acetic acid.
Destaining solution
The solution was made by mixing 250 ml methanol and 75 ml 
glacial acetic acid and the volume made to it with distilled 
water.
Preparation of gels
The separating gel was prepared first. A gel tube 
stoppered at one end was filled with small pore gel up to 5.5 cm
height. The gel was carefully layered with water. The gel
tube was placed under a fluorescent lamp (about 3 cm under the 
source of light) and exposed for 30 min. On polymerisation, 
the water layer was carefully removed and the inner wall of the 
tube thoroughly drained. Large pore gel (spacer gel) was 
layered on top of the separating gel to a height of 1 cm. The 
gel was layered with water and exposed to fluorescent light 
for 45 min.
Electrophoresis
Electrophoresis was carried out on the SHANDON ELECTROPHORESIS 
KIT CShandon Co. Ltd.). 8 gel tubes could be fitted to this
apparatus in a single run. 2mA current was used per gel. 
Electrophoresis was carried out at 4°.
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Pre-electrophoresis of the gels was carried out for 2h 
before application of samples.
Protein samples (10-20ug) were mixed with 1 drop of 
glycerol and 1 drop of tracking dye, and applied to the gel 
for electrophoresis.
The gels were stained for 20 min with Coomassie Blue. 
Destaining was achieved over a period of 36h with periodic 
changing of the destaining solution.
4.1.10.2 SDS-polyacrylamide disc-gel electrophoresis
The method employed here is a modification of the method 
developed by Weber and Osborn (118). It was principally 
developed as a method for determination of molecular weight.
Reagents
1. Gel buffer.
0.5 g SDS, 0.38 ml TEMED, 1.5 g TRIS and 120 g urea were 
dissolved in water and made up to 250 ml.
2. Acrylamide stock solution
38.7 g acrylamide and 2.66 g BIS were dissolved in water 
and made up to 1 0 0  ml.
3. Chamber buffer
3 g SDS and 6 g TRIS were dissolved in water and made 
up to it, and the solution adjusted to pH 7.5.
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4. Protein standard
Stock solution of proteins were as follows;
a. 5 mg.ml"^ human serum albumin
b. 5 mg. ml"^ bovine serum albumin
c. 5 mg.ml”  ^ myoglobulin
These solutions were diluted ten times with chamber buffer 
before use.
Preparation of gel
5% gel was prepared by mixing 2.5 ml acrylamide stock,
7.5 ml water, 0.02g ammonium persulphate and 10 ml gel buffer.
The gel mixture was poured into gel tubes and layered with water. 
The gel was polymerised under daylight and took about 20 min
for complete polymerisation.
Treatment of samples and standards before electrophoresis
Aliquots of protein solution (10-20^g) were mixed with lOyl 
2-raercaptoethanol and incubated at 37® for 2h.
Electrophoresis
Gels were subjected to Ih pre-electrophoresis before 
application of samples.
Samples were mixed with 1 drop of glycerol and 1 drop of 
tracking dye (as section 4.1.10.1). Electrophoresis was 
carried out at 4® for Ih, with a current of 2mA per gel applied 
(Apparatus was as described in section 4.1.10.1).
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Staining and destaining of gels were as described in 
section 4.1.10.1.
After destaining the gels were scanned on the VITRATON TLDlOO, 
with the following settings:
Settings
1. Lamp phototungst en
2. Slit 2.5 X 0.5
3, Filter 570nm
4. Level switch -b
5. Machine switch
6 . Chart speed
-3
7 (10 cm.min“
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4.1.11 Activity stain for uricase on acrylamide gel
The method was adapted from the method developed by 
Graham and Karnovsky (119).
Reagents 
Staining mediiam
3 mg 3-amino-9-ethylcarbazole was dissolved in 1 ml 
N,N-dimethyl formamide, and 10 ml 0.05M TRIS-HCl buffer 
pH 8.0. A drop of 5,6,7,8-tetrahydro-l-napthylamine was added 
and the mixture thoroughly stirred. After 2 min standing the 
mixture was filtered.
3 mg potassium urate, 3 mg peroxidase and 5 mg EDTA were 
added to the filtrate and the mixture thoroughly mixed.
Procedure
Polyacrylamide gels obtained immediately after electrophoresis 
(section 4.1.10) were rinsed with 0.15M NaCl and immediately 
incubated in ice-cold acetone for 10 min. The gels were rinsed 
with 0.15M NaCl and then incubated in the staining medium at 37° 
for at least 3h.
Appearance of reddish brown stain on the gel would indicate 
the presence of uricase activity on the gel. The gel was 
washed in the salt solution and fixed in 4 % formaldehyde for 2h.
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4.1.12 Molecular weight estimation by analytical ultra­
centrifugation
The molecular weight of purified uricase was determined by 
the method of Meniscus Depletion Sedimentation Equilibrium 
Analysis (119).
Procedure
Uricase sample in O.IM borate buffer pH 9.0 was dialysed 
against 50mM morate pH 10.0, containing O.IM ammonium sulphate 
for 24h. About 0.05 ml of the dialysed sample was required for 
analysis.
Instrument used
Spinco Model E Analytical Centrifuge (Beckman)
Conditions for centrifugation
Temperature - 20°
Speed - 15220 rpm
Cell - 12 mm, with double sector centre piece
(two 2.5° sectors)
Optical system - Rayleigh interference optics.
Fringe displacement were measured by means of a travelling 
microscope (Projectorscope, PG Ltd.), readings being taken at 
2 0 0  micron intervals, commencing at the meniscus along the 
x-scale. When a deflection of more than 10 microns occurred 
on the y scale between consecutive readings, the reading on the
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y scale was taken at 1 0 0  micron intervals.
The partial specific volume was taken as 0.74, and the 
specific gravity of the solution as 1 .0 .
The programme of Yphantis and Roark (120) was utilised 
in the computation of the molecular weight values from 
experimental data.
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4.2 Results
4.2.1 Extraction and purification of uricase from porcine liver
4.2.1.1 Preparation of crude uricase extract
The use of different buffer systems were investigated 
(section 4.1.1). Table 4.2.1.1.1 summarises the results 
obtained.
Buffer systems Activity
(U.ml-1 )
Protein 
(rag. ml~ ^ )
Specific Act. 
(U.mg~l)
O.IM borate, pH 10 0.085 61 0.00135
O.IM borate, pH 11 0.09 65 0.00138
O.IM borate, 1.5% 0.09 65 0.00138
Cw/v) Triton XlOO
pH 10
O.IM borate, 3%(w/v) 0.085 63 0.00135
n-butanol, pH 10
O.IM borate, 3%(w/v) 0.08 82 0 . 0 0 1 0
n-butanol, 1.5%(w/v)
Triton XlOO, pH 10
Table 4.2.1.1.1 Extraction of uricase with different buffer 
systems. All buffer systems contained ImM EDTA. The experiment 
is described in section 4.1.1.
The difference in the effeciency in terms of uricase 
extraction and protein solubilisation was minimal in all buffer 
systems studies, except in the buffer where both butanol and 
Triton XlOO were present.
66'
In this case there was significant increase in protein 
solubilisation.
The choice of O.IM borate buffer containing ImM EDTA 
and 1.5% (w/v) Triton XlOO, pH 10, was made in view of 
subsequent steps. Using this buffer the homogenate was stirred 
for 1.5h, after which no increase of uricase activity could be 
detected in the homogenate.
Dilution of this homogenate resulted in a further increase 
in the uricase content of the homogenate. Table 4.2.1.1.2 shows 
the result obtained when the homogenate was diluted in buffer 
containing Triton . XlOO (the homogenising buffer) and borate 
buffer containing no Triton XlOO.
Activity
(U.ml~l)
Protein 
(mg. ml~l)
% Total 
activity
% Total 
protein
Initial homogenate 0.085 65 1 0 0 1 0 0
Dilution buffer: 
Buffer without 
Triton XlOO 0.035 27 124 124
Buffer with 1.5%(w/v) 
Triton .XlOO 0.035 45 124 . 2 1 0
Table 4.2.1.1.2 Dilution of homogenate in the extraction of 
uricase. The initial homogenate was diluted with 2 volumes of 
the diluting buffer (section 4.1.1),
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Apparently the presence of excess detergent only promoted 
the solubilisation of more proteins without achieving any increase 
in the uricase content.
The ratio of dilution was largely determined by the need to
minimise the total volume of homogenate for the sake of
convenience. A ratio of 2:l(v/v) buffer to homogenate was
found to be minimum ratio permissible in view of the heat
treatment step. Lower dilution of the homogenate resulted in
coagulation of the homogenate on exposure to high temperature.
In effect, liver could have been homogenised in buffer containing 
0.5%(w/v) Triton XlOO.
Table 4,2,1,1.3 shows the typical results obtained when 
liver homogenate were heat treated as described in section 4.1.2.
Incubation 
period (min)
Activity
(U.ml-1 )
Protein 
(mg. ml”* ^ )
S p . Activity 
(0 .mg"*M
0 0.03 27.5 0 . 0 0 1
5 0.07 2 0 . 0 0.0035
1 0 0.05 17.5 0.003
2 0 0,03 16.25 0.0018
Table 4.2.1.1.3 Heat treatment of liver homogenate.
The experiment is as described in section 4.1.2. 100 ml volume
of homogenate was used for each period of incubation.
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The incubation period was found to be very critical and had 
to be adjusted according to the volume of homogenate used. The 
time required to raise and lower the temperature of the homogenate 
obviously depended on the volume of the homogenate and had to 
be considered.
The treatment of the liver homogenate to high temperature 
has the effect of increasing the uricase content of the homo?" 
genate (5 rain exposure to heat, in this case, proved to be 
optimal in getting high specific activity uricase).
Separation of n-butanol was a very significant step as most 
of the proteins and lipids were removed from the homogenate.
Table 4.2.1.1.4 summarises the results obtained in this 
procedure.
Procedure
Activity
(U.ml-1)
Protein 
(mg. ml“ ^)
S p . activity 
(U.mg-1)
Heat-treated
homogenate 0.08 2 0 0.004
Aqueous layer after
butanol separation 0 . 1 0 8 0.125
Table 4.2.1.1.4 n-Butanol separation of heat-treated liver 
homogenate. The experiment was as described in section 4.1.3
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There was significant purification (x 12.5) achieved though 
there was a decrease in the total uricase units (a decrease of 
around 2 0 %).
No uricase activity was detected in the supernatant after 
protein extract (.as prepared in section 4.1.3) was saturated 
to 40% with ammonium sulphate. Pig. 4.2.1.1.1 shows the activity 
and protein profile obtained when precipitate resulting from 
various stage of ammonium sulphate precipitation was re-extracted 
with a fixed volume of buffer. The results show that precipitate 
from 40% ammonium sulphate precipitation produces high specific 
activity uricase extract.
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Fig. 4.2.1.1.1 Activity and protein content of uricase extract 
obtained from precipitates acquired by different ammonium sulphate 
saturation. The precipitation and re-extraction procedure 
was as described in section 4.1.4. Keys to the Fig.: (y) indicates
uricase activity, and (V) indicates protein concentration.
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4.2.1.2 Ion exchange chromatography
The elution profile shown in Fig. 4.2.1.2.1 represents 
typical results obtained by chromatographic separation on 
DEAE-cellulose. At pH 8.5, 95% of uricase activity in the input 
sample (9 U) were absorbed onto a 7 ml DEAE-cellulose bed, but 
only 10 to 15% of the activity were finally eluted. About 5 fold 
purification was achieved in the uricase recovered. Variation 
of pH in the absorption or eluation process did not significantly 
alter the elution profile shown in Fig. 4.2.1.1.1. NaCl was 
also utilised in the eluant without further improvement in the 
elution of uricase.
4.2.1.3 Bioaffinity chromatography of uricase
Sepharose 4B was activated as described in section 4.1.6.1a, 
and oxirane groups attached to the Sepharose gel was determined 
as described in section 4.1.6.1b. 28-30pmole of oxirane per g 
of suction-dried Sepharose 4B were found.
Table 4.2.1.3.1 summarises the results obtained in the 
coupling of ligands to activated Sepharose 4B (section 4.1.6.1c). 
The amounts of ligand attached to the gel were calculated.by the 
nitrogen content of the gel, determined by the Kjeldahl method 
(section 4.1.6.Id).
The capacity of each Sepharose-ligand complex as an 
affinity adsorbent for uricase was investigated by the method 
described in section 4.1.6.2a, and the result is shown in 
Fig. 4.2.1.3.1.
Fig. 4.2,1.2.1 Elution profile of uricase separation on
DEAE-cellulose. (#) indicates uricase activity, (O) indicates 
protein concentration and dotted line represents salt gradient 
(0-0.25M). Sample was applied at point A and the salt gradient 
applied at point B.
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Concentration of 
coupling solution 
ClOO ml- 0 )
ymoles ligand 
per g. gel
Uric acid
1 g (0.059M) 14.25
14.5
14.3
0.5 g (0.03) 8 . 0
8.5
0.25 g (0.015M) 5.5
5.75
Xanthine
1 g (0.066M) 18.5
19.2
19.7
0.5 g (0.033M) 11.5
10.5
Cyanuric acid
1 g C0.0775M) 13.6
14.5
13.3
0.5 g C0.039M) 9.0
8 . 6
Oxonic acid
1 g C0.064M) 5.16
5.0
5.3
Table 4.2.1.3.1 Amount of ligands attached to activated Sepharose 
4B. Each reading is the average of 2 determinations. The different 
values for each concentration of ligand are for different preparations
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Although there was more xanthine bound per g Sepharose 
as compared to the amount of urate that was attached to the 
gel (Table 4.2.1.3.1), the capacity of Sepharose-xanthine was 
found to be only about 65% of the capacity of Sepharose-urate 
as the absorbent for uricase. No absorption was observed 
when uricase extract was passed through Sepharose-oxonate and 
Sepharose-cyanurate support. Even with very low flow rate 
no absorption of uricase was detected.
Uric acid has a very limited solubility in aqueous solution. 
At 4° only 3mM uric acid in O.IM borate pH 9.0 remained in 
solution, and 5mM uric acid stayed in solution (in the same 
buffer) at 20®. The limited solubility resulted in precipitation 
forming in the protein containing eluate.
Xanthine could be dissolved in O.IM borate pH 9.0 up to a 
concentration of 25mM. In experiments performed using 25mM 
xanthine solution, using the column elution technique, uricase 
was eluted in fairly large volume. Typically less than 40% 
adsorbed activity (70U) was recovered in the first 15 ml eluate.
25mM potassium oxonate in O.IM borate pH 9.0 proved to be 
a more suitable eluant. (This concentration of oxonate was also 
limited by the limited solubility of the compound in aqueous 
solution.) Generally 60% absorbed uricase was eluted in the 
first 12 ml of eluant, and about 70% of the absorbed uricase 
was collected in 25 ml eluant.
Fig, 4.2.1.3.1 The capacity of Sepharose-ligand for bioaffinity 
binding of uricase. The procedure was as described in section 
4.1.6.2a. Support with the highest ligand concentrations were 
used (Table 4.2.1.3.1). The percentage of total activity 
absorbed on Sepharose-urate (#) and Sepharose-xanthine (A) and the 
percentage activity bound per ml of sample input onto 
Sepharose-urate (O) and Sepharose-xanthine (A) are illustrated.
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As uricase-inhibitor eluates had to be separated by 
filtration through Sephadex G25, these values were actually 
calculated after the uricase had been eluted in the gel 
filtration procedure (section 4.1.7).
It was observed that recovery of enzyme was much higher 
(up to 90%) when small input of protein extract was applied 
to the affinity column (5-10 units of uricase).
Sepharose-urate support washed with eluant and 0.5M NaCl 
in buffer, could be reused for bioaffinity chromatography 
of uricase. There was an apparent decrease in the capacity 
of adsorption in the subsequent cycles (about 1 0 % of the maximum 
capacity in the second cycle, and 30% in the third cycle).
Uricase solutions were concentrated by the ultra-filtration 
method described in section 4.1.8. A decrease in activity of 
around 30% was observed in the case of many fold increases in 
concentrations of proteins (10 fold). Uricase has been 
concentrated to 1 mg protein ml“ ‘^.
Purified uricase was stored in O.IM borate buffer pH 10.0 at 
4°, without loss of activity in the period of up to 3 months.
Uricase stored in O.IM borate pH 9.0 at 4®, apparently 
precipitated out after 2 or 3 days when the protein concentration 
was 0 . 1  mg.ral"^ or greater.
Section 4.2.2 presents a summary of the final procedures 
adopted for the purification of uricase from procine liver.
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4,2.2 Pinal procedure for the purification of uricase from 
porcine liver
1. Homogenisation of porcine liver
Fresh liver, or liver already thawed was cut into small 
pieces and weighed. 400 g liver was homogenised in If of 
O.IM borate, ImM EDTA, and 1.5%(w/v) Triton x 100, pH 10, for 
1 min. The suspension was stirred for 2h at 4°. 2 volumes
of O.IM borate, pH 10 containing ImM EDTA were added to the 
homogenate and the suspension stirred for a further 30 min. The 
homogenate was then strained through muslin cloth. The residue 
was discarded.
2. Heat treatment
A 500 ml fraction of the diluted homogenate was placed in a 
2t conical flask and immersed in an 80® water bath. The flask 
was swirled and the temperature of the homogenate monitored.
When the temperature of the homogenate reached 60°, the flask
was immediately removed from the bath and stood at room temperature
for 5 min. After 5 min the flask was immediately immersed in
ice water and swirled to achieve rapid cooling, until the temperature
of homogenate fell to less than 1 0 °.
3. n-Butanol separation
n-Butanol was cooled at -20® overnight. n-Butanol and heat- 
treated homogenate (1:1,v/v) were mixed together. The alcohol
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was gradually added to the homogenate with constant stirring.
The suspension was then centrifuged for 60 min, at 2000 x g. 
The butanol layer and the protein-lipid layer were discarded, 
while the aqueous layer was collected.
4. Ammonium Sulphate precipitation
Finely powdered ammonium sulphate crystals were gradually 
added to ice-cold protein extract (aqueous layer from butanol 
separation), until 40% saturation was achieved. After Ih 
standing, the suspension was centrifuged at 5000 x g for 30 min.
The precipitate which separated at the top layer was 
carefully recovered. Uricase was extracted from the precipitate 
using O.IM borate ImM EDTA pH 10. The precipitate was stirred 
in the buffer for 30 min and centrifuged at 5000 x g for 30 min. 
The supernatant contained uricase activity, and was recovered.
The residue was re-extracted for any uricase remaining.
5. Bioaffinity chromatography
Affinity support was prepared as described in section 4.1.6.1. 
2 g Sepharose-uric support was packed in a small cylindrical glass 
column ( 1 x 6  cm). The column was filled to a height of 5 cm, 
and the affinity gel was equilibrated with O.IM borate, pH 9.0.
The column was maintained at 4°.
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Uricase extract was dialysed overnight in O.IM borate 
pH 9.0. The dialysed extract was perfused through the gel 
bed at 0.4 ml.min“ .^ Activity and protein content of the 
eluate was monitored. Sample input was terminated when the 
output (eluate) activity was about 1 0 % of the sample input.
The gel bed was then washed with O.IM borate buffer 
pH 9.0, containing 0.5M NaCl, to remove non-specifically 
adsorped proteins. The gel bed was then washed to remove the 
salt off the gel, using the equilibrating buffer.
Uricase was eluted from the affinity support by perfusing 
through the gel column 25mM oxonate (in O.IM borate, pH 9.0) at 
0.4 ml.min"^. Fractions (4 ml) of eluant were collected. 
Uricase should be eluted in the initial fractions.
To determine the units of uricase recovered, the eluates 
were passed through Sephadex G25 (section 4.1.7) .
Fig. 4.2.2.1 shows a typical adsorption and elution profine 
of uricase on a bioaffinity column. Table 4.2.2.1 summarises 
the purification procedures as described in this section.
Fig. 4.2.2.1 Adsorption and elution profile of uricase on the 
bioaffinity support. (O) denotes uricase activity, and (#) denotes 
protein concentration. Saiiple was applied at point A, buffer 
containing 0.5M NaCl at point B, equilibrating buffer at C, and 
eluant was applied at point D. 8 ml per fraction was collected.
A total of 117 units of uricase was applied and 85 units were 
recovered in the eluates.
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Table 4.2.2.1 A summary of the extraction and purification of 
uricase from porcine liver. For further details of the procedure 
see section 4.2.2.
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4.2.3 Characterisation of purified uricase
4.2.3.1 Gel filtration on Sephadex G20Q
Gel filtration on Sephadex G200 was carried out as described J;
in section 4.1.8. Void volume of the gel bed was found to be 
40 ml. 2 ml uricase (0.5 mg.ml“ )^ was applied to the gel
column, and uricase was eluted in about 60 ml elution volume.
ÏAbout 10% of input activity was lost in the filtration procedure.
No increase in specific activity was found.
4.2.3.2 Ultra-violet spectrum of purified uricase
Uricase solution (0.2 mg.ml” )^ was dialysed into O.IM 
borate buffer pH 10 for 16h. This solution was scanned on the 
Beckman DB GT spectrophotometer in the range of 320-220nm 
wavelength. The spectrum was recorded on the PYE UNICAM AR45
recorder, as shown in Fig. 4.2.3.2.1. The maximum absorption of
purified uricase is found to be at 277nm.
4.2.3.3 Polyacrylamide disc-gel electrophoresis
Two different methods were adopted in studying the 
characteristics of purified uricase in polyacrylamide 
electrophoresis. ^
Pig. 4.2.3.3.1 shows a photograph of electrophoresis gels 
after protein and activity staining obtained by the method 
described in section 4.1.10.1. There was essentially a single 
protein band which corresponded to the band of activity stain. No
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Fig. 4.2.3.2.1 Ultra-violet spectrum of purified uricase
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Fig. 4.2.3.3.1 Disc-gel electrophoresis patterns of purified 
uricase (section 4.1.10.1).
A: 20yg uricase, electrophoresis ran at pH 8.5.
B: lOyg uricase, electrophoresis ran at pH 8.5
C: lOyg uricase (after Sephadex G200 filtration), electrophoresis
ran at pH 8.5.
D; lOyg uricase, electrophoresis ran at pH 9.0.
E; 20yg uricase, electrophoresis ran at pH 8.5;
activity stain.
J
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significant difference was observed when the electrophoresis was 
carried out at pH 8.5 and 9.0. Enzyme samples obtained after 
Sephadex G200 filtration showed identical results with uricase 
samples obtained from Sephadex G25.
Gel electrophoresis in the presence of SDS also resulted 
in a single protein band migrating down the gel. However no 
uricase activity was detected on the gel by activity staining 
(section 4.1.11).
It was observed that this single protein band could be 
detected even without pre-treatment of the uricase sample with 
SDS-glycine buffer and 2-mercaptoethanol (section 4.1.10.2).
4.2.3.4 Molecular weight estimation of purified uricase
Molecular weight was initially estimated by the SDS- 
polyacrylamide disc-gel electrophoresis (section 4.1.10.2). By 
applying standard proteins to the electrophoresis, the migration 
of different proteins down the gels could be compared (Fig. 4.2.3.4.1) 
A plot of molecular weights against the corresponding mobility 
of the protein bands is shown in Fig. 4.2.3.4.2. The molecular 
weight of purified uricase was estimated using this plot.
M b ‘l*t = distance of protein migration length of gel after destaining
X d^^9 th of gel before staining 
distance moved by tracking dye
Molecular weight of uricase estimated by this method was 
in the range 32-34 x 10^.
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*
B
Fig. 4.2.3.4.1 SDS-acrylamide disc-gel electrophoresis patterns 
lOyg uricase samples, untreated (A) and treated (B) were applied 
to the gels. (C) denotes the gel with standard proteins.
For further details see section 4.1.10.2.
J
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Fig, 4.2.3.4.2 Calibration plot for the estimation of molecular 
weight by SDS-acrylamide disc-gel electrophoresis.
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Molecular weight was also estimated by the ultra­
centrifugation method described in section 4.1.12.
Fig. 4.2.3.4.3 shows the optical pattern obtained from the 
ultracentrifugation method. Measurement of the interference 
pattern and computer analysis of the data into a programme, 
the molecular weight of the protein sample could be estimated.
Fig. 4.2.3.4.4 shows a plot of inverse sigma (^ ) against 
concentration (proportional to the fringe displacement), where,
^ _ Mi(l - vp.)w^
is the "reduced molecular weight". Mi is the molecular weight 
for the protein, Vi is its partial specific volume, p is the 
solution density, w is the angular speed, R is the gas constant 
and T is the absolute temperature.
From the computer result,
RT
(.1 - ViP)w' = 36903
The values of sigma along the concentration gradient was 
also computed. From the plot (Fig. 4.2.3.4.4) the value of 
sigma at zero concentration was postulated, and Mi was 
calculated as 1.34 x 10^.
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Fig. 4.2.3.4.3 Interference pattern obtained by the ultra­
centrifugation method.
Fig. 4.2.3.4.4 Plot of inverse sigma against concentration, j
for the estimation of molecular weight.
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4.2.4 Determination of the kinetic parameters of purified 
uricase
4.2.4.1 Determination of and V^ax
The Km and Vmax of purified uricase were determined from 
initial velocity data by the graphical method of Lineweaver and 
Burk . (121) and also by fitting initial velocity data to the 
hyperbolic Michaelis-Menten equation using an ALGOL-W computer 
programme (1 2 2 ).
The initial velocity for a range of substrate concentration 
of 0.004 ~ O.OSmM were measured by the oxygen electrode method 
(section 3.1.1). The reactions were carried out in O.IM 
borate buffer pH 8 . 6  at 25°.
The double reciprocal plot for the determination of and 
Vmax i-s shown in Fig. 4.2.4.1.1. Table 4.2.4.1.1 shows the 
results obtained by the two methods.
^max ^ a xMethods
(U.mg-1) (M)
Double-reciprocal plot 12.6 1.04 X 10~5
ALGOL-W computer analysis 12.56 ± 0.28 1.03 ± 0.06 X 10-5
Table 4.2.4.1.1 K^ and values for purified uricase.
Pig. 4.2.4.1.1 Double-reciprocal plot for the detiermination 
of Km and Vmax* Each velocity value was the mean of three
determinations. The best fit line was drawn through the points.
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4.2.4.2 pH profile of purified uricase
The pH-activity profile of uricase was determined by 
assaying the enzyme in a range of suitable buffers. The 
rate of reaction was monitored by the method described in 
section 3.1.1.
A pH range of 6.5-11.0 was used with different buffer 
systems. The results were plotted with activity expressed 
as the percentage of maximum activity against pH as shown 
in Fig. 4.2.4.2.1. The optimum pH was to be in the range 
of 8.9 to 9.1.
4.2.4.3 Thermal dénaturation of uricase
0.5 ml aliquots of uricase (0.1 and 0.2 mg.ml""^) in
O.IM borate buffer pH 10.0 were incubated in a constant temperature 
bath in the range of 25°-60°, for set time periods (within the 
range 5-60 min). At the end of the incubation period the 
enzyme was cooled in an ice bath and 0 . 1 ml aliquots were 
assayed for residual activity.
A plot of residual activity (expressed as the percentage 
of maximum activity) against incubation period is presented 
in Fig. 4.2.4.3.1.
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Fig. 4.2,4.2.1 pH profile of purified uricase. The enzyme 
was assayed in phosphate (•), TRIS (O), borate (▼) and glycine 
buffers (♦) .
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Fig. 4.2.4.3.1 Thermal dénaturation of uricase. The enzyme 
was incubated at 25® (#), 37® (O), 45® (*), 50® (a), 55® (t) 
and 60® (y) .
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4.3 Discussion
The initial stages of the purification process were devised 
for obtaining protein extract with high uricase content, suitable 
for application to the bioaffinity procedure. With consideration 
that the process should be adaptable to large scale techniques, 
the procedures were developed with the following objectives in 
mind.
1. To maximise the extraction of the enzyme from liver.
2. To minimise the volumes to be handled during the purification 
process.
3. To eliminate high speed centrifugation procedure in the 
process.
Alkaline pH solutions were chosen for extracting uricase 
due to its stability and solubility in such pH ranges (111,112). 
The difference in the total units of extracted uricase in solution 
of pH 10 and 11 was rather minimal, although Yokota (43) 
obtained more significant differences. The presence of Triton 
XlOO and n-butanol increased the solubility of proteins, but the 
primary role of the detergent and alcohol may have been in the 
disintegration and dissociation of the uricase from the nucleod 
cores of the microbodies.
The presence of n-butanol in the extracting buffer may 
not be suitable especially if the homogenate were to be exposed 
to heat. Leone (44) and London and Hudson (45) did however 
utilise warm n-butanol-buffer solution for extracting uricase
I'I
-I
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but the recoveries were rather low.
Triton XlOO, a neutral detergent, was found to be more
suitable for uricase extraction in preference to cationic detergents(1 1 0 )*
although Otta and Bertini (111), using Hyamine 2389, a cationic
detergent, found the contrary. The presence of Triton XlOO
increased the extraction of uricase and protein solubilisation.
In fact, varying concentration of Triton XlOO affected the
solubility of proteins, and excessive amount of the detergent
only served to increase protein content without increasing
uricase content. A suitable concentration of the detergent in
the extraction procedure should be used to obtain uricase with
high specific activity. Truscoe (110) used 1.5% Triton XlOO
in the extracting buffer to obtain high specific activity enzyme,
but in this work 0.5% detergent in buffer was used with good
effect. Obviously the volume of extracting buffer was the 
limiting factor.
Heat treatment of the homogenate may further promote the 
dissociation of uricase from the crystalloid cores, though the 
increase in uricase content may also be attributed to the 
destruction of inhibitory agents.
The quantity of uricase extracted (over 300 units from 
400 g liver) is high compared to previous preparations (41-43).
The n-butanol separation technique provided a mean of 
separating most of the unwanted proteins and lipids. Significantly 
this was the first step in which centrifugation was utilised.
Sufficient separation of the phases was obtained under low speed
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centrifugation, and the uricase active layer could be collected 
with little loss in activity.
Ammonium sulphate precipitation is a commonly used procedure 
for purification and concentration of enzyme solutions. Mahler 
et al.(42) used a 2-step precipitation procedure to remove 
non-uricase protein in the first instance and to precipitate 
uricase in the second. A similar principle was followed here 
but with a single precipitation step followed by re-extraction 
of the precipitate for uricase. This procedure was more 
convenient as there is a smaller volume in the re-extraction step,
The behaviour of uricase on DEAE-cellulose may be explained 
by the high affinity between opposite charges of the enzyme and 
the ion exchangers, indicating that uricase molecules are 
polyanionic under the conditions studied. Truscoe (110) 
showed that uricase was irreversibly inhibited by cationic 
detergents, comprising quarternary ammonium salts, due to the 
formation of complexes. In another work, long chain alkyl 
groups seemed to be involved in the inhibitory effect (123). 
Nevertheless the formation of these complexes may contribute to 
the inability to elute uricase from the ion exchanger. DEAE- 
cellulose chromatography achieved some purification of uricase, 
but the recovery was too low for this technique to be of much 
use.
The degree of purification and high recovery achieved by 
the bioaffinity chromatography process explain the increasing
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popularity of this technique in recent years in enzyme purification.
Uric acid, the substrate and xanthine, a relatively strong 
purine inhibitor (K^ - 1 . 2  x 1 0 “%)  of uricase (5 5 ) were used as 
ligands. Prodovich (124) showed that s-triazines, oxonic acid 
(Ki - 1 X 10” %)  and cyanuric acid (K^ - 3 x 10”%) were also 
competitive inhibitors of uricase, and because of their greater 
solubility in aqueous solutions were also considered as ligands.
All these compounds have chemical groups which may be suitable 
for coupling to oxirane activated supports. Fig. 4.3.1 shows 
the possible configurations of these ligands and supports 
after coupling.
However, the coupled s-triazines were found to be unsuitable 
ligands. Uricase shows no affinity for these supports under 
the conditions investigated. It was thought that the inhibitory 
effect was promoted by the s-triazine ring, which was similar 
to part of the purine ring, and substituting one of its available 
hydroxyl groups would not significantly alter its inhibitory 
property. Furthermore, substituted pyrimidines have also been 
shown to possess inhibitory effects on uricase (125). It seems 
that the presence of long chain groups substituted into the 
s-triazine ring is detrimental to the inhibitory property of these 
compounds. Loss of inhibitory capacity may be due to inaccessibility 
of the s-triazine molecule to the active site of the enzyme.
Curling up of the long chain spacer 'arm', thus masking the ligands 
cannot be ruled out.
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Fig. 4.3.1 Possible configurations for Sepharose-ligand, 
coupling.
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Successful adsorption was achieved with coupled urate and 
xanthine. It was notable that more xanthine was coupled per g 
support but the adsorption capacity was less than the urate- 
support complex. Obviously the substituted urate has greater 
affinity for uricase than the substituted xanthine, although the 
chemistry of coupling may be more suitable to the xanthine 
molecule.
High enzyme recovery can be achieved by the bioaffinity 
technique. In this work, the final recovery (ca.70%) may be 
lower than expected but the enzyme was not measured until the 
inhibitor was removed from the eluate by gel filtration.
Exposure of uricase to the Sephadex surfaces may have denatured 
some of the uricase (47,110). Filtration through Sephadex G200 
resulted in some loss of activity. The long exposure of 
uricase to the surfaces of the Sepharose support during 
the bioaffinity chromatography step cannot be disregarded as a 
factor in the dénaturation of the enzyme.
Inhibitors may not be ideal for elution of enzyme from 
affinity supports. Complete separation of the enzyme from the 
inhibitor may be difficult due to the affinity of the inhibitor 
for the enzyme molecule. Apparent low enzyme activity may be 
measured unless the inhibitors can be completely dissociated 
from the enzyme molecules. Substrate(s) or co-substrate(s) 
may be better eluting agents, but in the case of uricase, the 
use of its substrate was limited by its low solubility.
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High purity enzyme was obtained by this purification process. 
The average specific activity of 8 U.mg”  ^ is high compared to 
most commercial preparations, and the recovery of enzyme is 
significantly higher than those obtained by many previous 
workers (especially when the total units of uricase available 
is also higher).
Homogeneity of the purified uricase was shown by gel 
electrophoresis where a single protein band was obtained. 
Interestingly, a single protein band was also obtained with lower 
specific activity uricase (43) possibly pointing to the isolation 
of partially denatured uricase.
The clear interference pattern of the Rayleigh optics in 
the ultracentrifugation system provided further evidence of the 
homogeneity of the enzyme preparation.
The ultra-violet spectrum of the purified uricase is similar 
to those obtained previously in earlier work (43,57).
The of the purified uricase is found to be 12.6 U.mg” ,^
and the value is about 1 x 10“% .  Yokota (43) obtained
and values of 5.4 U.mg“  ^ and 5.8 x 10”%  respectively. Kjji
values closer to the value obtained here were obtained by Baum
et al. (56) (1.7 x 10“ %), Fridovich (124) (0.5 x 10“%)  and Sedor
and Sander (125) (0.78 x 10“% )  . Obviously the variations may
be attributed to the non-standardised assay conditions, such as
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buffer, temperature and substrate range. Variations in values 
can also be affected by the oxygen concentration in the assay 
solution.
The pH optimum of the purified uricase is about 9, a value 
corresponding to that obtained by Baum e^ al.(56) and is also 
close to the value obtained for bovine kidney uricase (44). 
However, Yokota (43) obtained a pH optimum of 9.6 for porcine 
liver uricase.
Two different values of molecular weights obtained can 
be attributed to the dissociation of the uricase molecule.
The 'true' molecular weight of the native uricase is about 
134,000, a value comparable to those obtained by Mahler (57),
Leone (44) and Pitts et al.(126).
Pitts ot al.(126) showed that uricase comprised four equal 
sub-units of molecular sub-units of molecular weight 32,000, 
a value obtained in this work, obtained by the SDS-gel electro­
phoresis. The absence of activity on the protein band on the gel 
indicates the loss of activity after dissociation. It was 
observed that dissociation could be achieved during electro­
phoresis without prior treatment, whereas Pitts ^  found 
that it required prolonged heating in SDS for dissociation to 
occur.
Pitts e^ al. (126) activated uricase in glycine buffer 
showed that uricase was fairly stable up to 47®. In this work, 
uricase appeared to be less stable in borate buffer, the enzyme 
being stable up to 25®. Apparently, the enzyme is much more 
stable in glycine buffer.
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5. imOBILlSATION OF URICASE ONTO NYLON TUBE
5.1 Methods
5.1.1 Activation of nylon tiibe by 0-alkylation
5.1.1.1 Preparation of triethyloxomium tetrafluoroborate (TOTFB)
The method used is based on that described by Meerwein (127). 
The reaction is illustrated in Fig. 5.1.1.1.1.
Procedure
Boron trifluoride diethyletherate (25 g) was added to 200 ml 
dry diethyl ether in a round bottomed flask fitted with a reflux 
condenser. The solution was brought to reflux and 12.5 g 
l-chloro-2:3-epoxypropane in 50 ml diethyl ether was gradually 
added to the solution and the mixture stirred under reflux for 
2h.TOTFB precipitated as white crystals and was washed thoroughly 
with (4 X 100 ml) diethyl ether. The precipitate was dissolved 
in 200 ml dry dichloromethane and used within 24h of preparation.
5.1.1.2 0-alkylation of nylon tube
This procedure was optimised by Noy (92).
Procedure
Nylon tubings (.2m lengths) filled with TOTFB solution 
(section 5.1.1.1) and sealed end to end were incubated at 25® 
for 15 min. The alkylation was terminated by washing with dry 
dichloromethane.
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3 C1 .CH2 .CH - CH2 + 2 (C2Hs) 0 + 4 (C2H 5) 2 .OBF3
^ 0 ^
l-chloro“2:3-epoxy diethyl Boron trifluoride
propane ether diethyletherate.
reflux
3 (C2H 5 )3 0+BP- +
TOTFB.
CI.CH2CHO
CH2 .OC2H 5
Fig. 5.1.1.1.1 Preparation of TOTFB as described in 
section 5.1.1.1.
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5.1.1.3 Attachment of spacer to 0-alkylated nylon tube 
Reagents
1. Diaminoethane, 2M in methanol.
2. Adipid hydrazide, 4%(w/v) in formamide.
3. PEI, 20%(v/v) in methanol.
Procedure
O-alkylated nylon tube as prepared in section 5.1.1.2 
was filled with appropriate spacer solution, sealed end to end 
and was incubated at room temperature. Excess amine or 
hydrazide was removed by washing with a large volume of water.
5.1.1.4 Coupling of enzyme to amine- or hydrazide substituted 
nylon ' tube
a. Reactivation of amine or hydrazide substituted nylon tube
i . Glutaraldehyde coupling
Procedure
Amine or hydrazide substituted nylon tube was perfused with 
5%(w/v) glutaraldehyde in 0.2M borate buffer pH 8.5. The 
solution was recycled through the nylon tube for 15 min. The 
tube was free of excess glutaraldehyde by perfusion with 0.5M NaCl 
in 0.2M borate buffer pH 8.5. The tube was then washed through 
with the coupling buffer and used for enzyme coupling immediately.
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ii. Bisimidate coupling
Amine or hydrazide substituted nylon tube was perfused with 
dry methanol and sucked dry by suction pump. The tube was 
recycled with a solution comprising 4%(w/v) dimethyl suberimidate, 
in 40%(v/v) N-ethylmorpholine in methanol. After 10 min the 
tube was washed dry with methanol and then used for enzyme 
coupling immediately.
b. Enzyme coupling to reactivated nylon tube
Nylon tube reactivated by glutaraldehyde or bisimidate 
(section 5.1.1.4a) was filled with enzyme solution to be 
immobilised.
Typically glucose oxidase (1 mg.ml"’^ ) in 0.2M borate buffer 
pH 8.5 was incubated in an activated nylon tube at 4® for 3h.
The activity of pre- and post-coupling enzyme solution was 
assayed as described in section 3.1.2. The protein concentration 
of the solutions was assayed according to the methods described 
in section 3.2 or monitored at 280nm.
Unbound enzyme was washed from the nylon tube with buffer 
containing 0.5M NaCl.
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5.1.2 Glutaraldehyde activation of nylon
5.1.2.1 Optimisation of conditions of activation for maximum 
activity retention
Glutaraldehyde has been used as a coupler to attach enz;^es 
to amino-derivatised nylon tube. Optimum conditions for this 
reaction was studied by Onyezili (128) . It was found that under 
certain conditions glutaraldehyde was able to attach directly 
to the nylon polymer, to produce reactive centres. These conditions 
were investigated.
Glucose oxidase (GOD) was initially used as an index to 
assess the effect of varying conditions of activation. This 
enzyme was chosen, as it had been immobilised to nylon tube 
successfully, and it was available at fairly low cost.
The activity of GOD on the nylon tube was assessed by 
incorporating the immobilised enzyme tube into a standard 
Technicon AAl continuous flow analyser (AutoAnalyser) where it 
was perfused with substrate at a fixed flow rate and the amount 
of product formed was measured. At low percentage conversion 
the product would be proportional to the enzymic activity.
The activity of GOD was determined by the method described 
by Trinder (129). GOD catalysed the oxidation of glucose to 
yield gluconic acid and hydrogen peroxide. Hydrogen peroxide 
was then allowed to oxidise 4-aminophenazone (APZ) and phenol 
in a reaction catalysed by peroxidase (POD). A reddish pink
109
quinone is formed, this product being proportional to the glucose 
oxidised.
GODg-D-glucose + 0% + H 2O *..... ■"■> 3-D-gluconic acid + H 2O 2
H2O2 t CH3 -G~ ~ C.NH2
CH .
PheIPhe
POD
f/ %
Phenol
)H
CH3 .C" c .N(/ oI I \ _ /CH .N. ^c=0 ^ '
Phe • tPhe + H 2O
Note: Phe
Protein coupled was monitored by the absorption at 280nm 
of the pre- and post-coupling solutions.
Reagents
1. O.IM phosphate pH 7.0 containing 0.05%(v/v) Triton XlOO 
and 0.33M Na2S0 i^ .
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2. Colour reagents.
Reagent A: 1 g phenol was dissolved in O.lM phosphate and
made up to l£.
Reagent B; 60 mg APZ and 2 mg POD were dissolved in O.lM 
phosphate pH 7.0 and the solution made up to 100 ml.
3. Glucose standard.
25mM glucose solution was made in saturated benzoic acid.
Procedure
Nylon tube (Im length) was coiled around a perspex cylinder 
and filled with glutaraldehyde solution. The tube was then 
sealed end to end and immersed in a constant temperature bath for 
a set period of time. The tube was washed clear of excess 
glutaraldehyde with 0.5M NaCl solution and subsequently filled 
with PEI solution and incubated at room temperature for 2h.
The PEI-derivatised nylon tube was washed free of excess 
unbound PEI with a large volume of water.
Glutaraldehyde coupling of enzyme (section 5.1.1.4a, i) 
was utilised for immobilising GOD to the PEI-derivatised nylon 
tube.
GOD (1 m g .ml"^) in 0.2M borate buffer pH 8.5 was incubated 
in the reactivated tube at 4° for 3h.
The tube was thoroughly washed with 0.5M NaCl in O.lM 
phosphate pH 7.0, to remove non-covalently bound protein.
Ill
The immobilised enzyme tube (25 cm) was incorporated 
into the flow system as shown in Fig.5.1.2,1.1.
Conditions for glutaraldehyde activation of nylon were 
varied to obtain the optimal conditions for enzyme immobilisation.
a. Variation in glutaraldehyde concentration
Glutaraldehyde solution (25%, w/v) was diluted to varying 
concentration ranging from 1.25 to 18.5% in 0.5M borate pH 9.0. 
Nylon tube filled with the glutaraldehyde solution was incubated 
for 10 min in a 90® bath.
b. Variation in the period of incubation
Nylon tube was filled with 18.5%(w/v) glutaraldehyde in
0.5M borate buffer pH 9.0 and incubated at 90® for 2.5-30 min.
c. Variation in teirperature of incubation
Nylon tube was filled with 18.5%(w/v) glutaraldehyde in
0.5M borate buffer pH 9.0 and immersed in constant temperature
baths at temperatures ranging from 0-90® for 15 min.
d. Variation of pH of glutaraldehyde solution
Nylon tube was filled with 18.5%(w/v) glutaraldehyde in
0.5M buffer of different pH values. The tube was incubated 
for 15 min at 90®.
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Air :1
MOBuffer2
Sample3
Reagent A4
Reagent B5
Wash6
7
5 C 5 n m
Fig. 5.1.2.1.1 Flow system for assaying the activity of
immobilised GOD tube. The system consists of standard 
Technicon AutoAnalyser AAl modules. The mixing coils (MC) 
and the enzyme tube (ET) are maintained at 37®. (W) indicates
waste line.
Keys to Fig. 5.1.2.1.1
Pumping line Flow rate (ml.min""
1. Air 0.8
2. Buffer 1.6
3. Sample 0.16
4. Colour reagent A 0.23
5. Colour reagent B 0.23
6 . Wash line; buffer 1.0
7. Flow cell 1.6
Sampling rate; 60 samples.h""^ .
Sample to wash ratio: 2:1
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Buffers used:
citrate pH 3.4 - 5.5
acetate 4.5 - 5.5
phosphate 6.5 - 7.6
borate 8.5 - 10.0
5.1,2.2 Variation in PEI concentration
PEI was diluted in water and used as a spacer molecule 
between the nylon backbone and the enzyme molecule.
Procedure
Nylon tube was activated by 18.5%(w/v) glutaraldehyde in
0.5M borate buffer pH 9.0, and incubated at 90® for 15 min.
PEI was diluted to 1-10(w/v) in water. Activated nylon
tube was filled with the diluted PEI solution and incubated at 
room temperature for 2h,
The tube was washed with a large volume of water to remove 
excess unbound PEI, and GOD was immobilised as described in 
section 5.1.1.4.
3
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5.1.3 Preparation of nylon iicmiobilised uricase 
Reagents
1. Uricase; purified uricase was obtained by the purification 
procedure described in section 4.2.2. Uricase in borate 
buffer was titrated to pH 8.5-9,0 for coupling to 
activated tube.
Procedure
Nylon tube was activated directly with glutaraldehyde. 
Typically 2m nylon tube was wound around a perspex cylinder and 
filled with 18.5%(w/v) glutaraldehyde in 0.5M borate buffer 
pH 9.0. The tube was sealed end to end and incubated at 90® 
for 15 min.
The tube was washed with 0.5M NaCl solution and filled with 
10%Cw/v) PEI solution in water. The tube was incubated at room 
temperature for 2h.
The, derivatised nylon tube was reactivated by either 
glutaraldehyde or bisimidate as described in section 5.1.1.5, 
before coupling of enzyme.
Reactivated nylon tube was filled with the enzyme solution 
and incubated for 3h at 4®. After coupling the tube was washed 
with 50mM glycine pH 9.0 containing 0.2M NaCl.
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5.1.4 Assay of immobilised enzyme
5.1.4.1 Theory
The activity of a tubular enzyme reactor can be assayed by 
the recycling method described by Ford et al.(130). This method 
simulates soluble assay conditions and is preferred by many 
workers. Activity of an enzyme tube can be calculated by the 
formula;
V = _ ds (TV)dt L
where,
V is the activity of enzyme derivative (ymole.min.“ ^m~^).
- is the observed rate of change in the substrate concentration. 
TV is the total volume of assay (ml).
L is the length of enzyme tube (m).
Noy (92) adopted this method to assay alcohol, aldehyde 
and lactic dehydrogenase (lactic dehydrogenase; L-lactate:
NAD oxidoreductase, EC 1.1.1.27) immobilised to nylon tube.
These enzyme-catalysed reactions which use or liberate NADH, 
can be monitored at 340nm in a flow through cell.
In the case of uricase the reaction products are not easily 
monitored in this kind of system. A method involving the 
integrated form of Michaelis-Menten equation using single pass 
technique is more adaptable.
Two approaches are taken in using this method.
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a. For changing urate concentration, zero order kinetics was 
assumed with respect to oxygen.
The Michaelis-Menten equation is given by:
_ = Vs _ V ^dt s + Kj^  1 + Kj /^s
where s - substrate concentration 
V - maximum velocity 
- Michaelis constant
Thus,
/  ®t I*
- J f  
4 .  4
(St - So) - = vt
where,
Sq - initial substrate concentration 
S,j- - substrate concentration at time t
If p = go ~-St.
So
Equation 2 becomes,
FSo - Kjnlnd - F) = Vt 3
V = Kg CE) • 4
where,
-1 -1Kg - .rate ^ constant • mg. enzyme )
CE) - concentration of enzyme (mg.ml“ )^
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In a tubular reactor, 
Trr^Lt = Q
where,
L - length of tube (m)
Q - flow rate of substrate through tube (ml.min"'^)
r - radius of tube (m)
t - residence time of substrate in the tube, assuming
piston flow (min.).
Now if,
- surface concentration of enzyme (mg.m“^).
Total amount of enzyme in the tube;
= 2TrrLE_
Volume of tube = irr^ L
i.e. (E) =
If is the .apparent activAjty of .thp tube per unit, length • 
—1 —1(pmple.min. m ), then,
Total Activity;
k^L = Kg2irrLEa
V —  ; Isti- 7s 27rrEa
Therefore, substituting v = Kg(E) with equations 5, 6 and 7,
V t  = - kf' . ÊgaTT, r fb
2iTrEa r Q
Vt
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Substituting equation 8 into equation 3,
FSo - Kjn'lnCl - F) = k^LQ-1 9
where Kju' - apparent Michaelis constant for the immobilised 
enzyme.
Rearranging equation 9,
FSo = K^.lnCl - F) + k».LQ“i 10
If values of F are measured at different initial concentration 
Sq at constant flow rate Q, then FSq plotted against ln(l - F) 
will give a straight line if K^i and k.}/ are constant at that flow 
rate.
The slope of the line will be equal to and the intercept 
on the FSq axis will be equal to ktLQ“ .^
b. When only the maximum activity of the immobilised enzyme 
(k^l is required, a more simplified approach is taken.
The rate of uricase catalysed reaction is given by.
VV = Su. + gOi . .(D) (O2 )
where,
V - the rate of reaction
V - maximum rate of reaction
Ku “ the Michaelis constant for urate 
CU) - the concentration of urate 
Kq 2 - the Michaelis constant for oxygen 
(0%) - the concentration of oxygen
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If the urate concentration is kept high with respect to K^, 
then
K.u
(U) «  1
Equation 1 is approximated to
V V1 + Ko,
(O2 )
(0%) in air saturated water is 0.23rnM.
i.e./
d(02) _ V
dt 1 +
CO2)
Integrating equation 3,
(0 2 ) 0  - (Oz)t (02 >t (On) O Vt
(0 2 ) 0  - (02)t 
( O ^ F, the fractional conversion,
Equation 4 becomes,
F (0 2 ) 0  - Ko^l n d  - F) = Vt
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The series,
ln(l + x) = X - l/2x^ + 1/3x3 - l/4x^ 
thus,
ln(l - F) = -F - 1/2F2 - l/SF^ - 1/4x4
If F «  1, say F < 0.15,
ln(l - F) can be approximated to -F
Equation 5 becomes,
F (0 2 ) 0  + K0 9 F = Vt
F =
'2
Vt
{0 2 ) 0  + K0 2
V
t (0 2 ) 0  + K0 2
The fraction of substrate to produce conversion, F, is measured 
by the hydrogen peroxide produced in the reaction.
F =_ (H2O 2 )230
(H2O 2 ) - pmole.ml~^
where,
t - time of residence of assay mixture in the tube (min) 
Therefore, substituting t in equation 7,
V = H  9
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Thus, the activity of the enzyme tube can be determined 
if the fraction of substrate consumed in the reaction, the 
flow rate of substrate through the enzyme tube and the volume 
of substrate assayed are measured.
Hydrogen peroxide produced in uricase catalysed reaction 
was determined by a coupling reaction involving two oxidative 
reactants, 4-aminophenazone(APZ) and dichlorohydroxy benzoyl 
sulphonate, catalysed by peroxidase (POD).
5.1.4.2 Preparation of dichlorohydroxy benzoyl sulphonate (HBS) 
Procedure
3,5-dichloro-2“hydroxybenzene sulphonyl chloride (100 g) 
was gradually added to I.SZ. of distilled water with constant 
stirring. Sodium carbonate (40 g) was added to the mixture 
and the stirring continued for 2h at room temperature,
All undissolved materials were removed by vacuum filtration 
on a sintered glass funnel. The filtrate was evaporated on a 
rotary evaporator at 40®.
The white powder produced was dried over air and stored at 
room temperature.
5.1.4.3 Methods for assaying immobilised enzyme 
Reagents
1. Colour reagents
A. HBS C3.5 mg.ml“ )^ in 0.2M phosphate buffer pH 7.0.
(17mM)
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B. APZ CO.3 mg.ml“^) in phosphate buffer pH 7.0, (l,5mM), 
and 0.02 mg.ml~^ POD in 0.2M phosphate pH 7.0.
2. Hydrogen peroxide standard
A stock solution of about lOOmM was stored in a dark bottle 
at 4°. Prior to use, the concentration of H 2O 2 was 
determined with acidified solutions of potassium permanganate 
Working solutions were prepared by dilution in ice-cold 
water.
a. Immobilised GOD
3. Buffer; O.lM phosphate buffer pH 7.0, containing O.lM 
Na^SO^.
4. Substrate; 0.5M D-glucose in buffer.
b. Immobilised uricase
5. Buffer; 50raM borate buffer, O.lM NaCl pH 8.6.
6. Substrate; 2mM uric acid was dissolved in the above buffer
and diluted accordingly.
Procedure
A suitable length of immobilised enzyme tube ( 5 - 2 0  cm) 
was incorporated into the flow system shown in Fig. 5.1.4.3.1. 
Unless otherwise specified, the substrate flow through the system 
was air-segmented. Substrate was pumped through the enzyme tube
at a certain flow rate, Q ml.min"^ and 5 ml aliquots of effluent 
were collected.
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Air
Substrate E T< n m
>i
Fig. 5.1,4.3.1 Flow system for assaying immobilised enzyme (ET).
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1 ml of reagent A and 1 ml of reagent B were added to the 
effluent and incubated at 25° for 15 min. Absorbance was read 
at 517nm.
A calibration plot was obtained by assaying standard 
solutions of hydrogen peroxide (Fig. 5.1.4.3.2).
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0*9
0-8
0 7
£ 0:6
0-5
< 0 4
ûQ 0-3
0 2
01
0 1
Pig. 5.1.4.3-.2 Calibration plot for determination of hydrogen 
peroxide.
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5.2 Results
5.2.1 Optimisation of glutaraldehyde activation of nylon tube
The optimal conditions for activation of nylon tube were 
studied. Glucose oxidase (GOD) was used as an index of the 
capacity of the activated nylon tube for enzyme retention on 
immobilisation. PEI was used as the spacer (section 5.1.2) 
and glutaraldehyde was used as the coupling reagent for enzyme 
immobilisation (section 5.1.1.4). The activity of each enzyme 
tube was assayed as described in section 5.1.2, and was expressed 
as a percentage of maximum tube activity obtained, i.e. as a 
relative activity.
Nylon tube treated with glutaraldehyde solution turned 
yellow in colour. Increased concentration of glutaraldehyde 
produced enzyme tubes with increased activity retention.
Fig. 5.2.1.1 showed the effect of increasing glutaraldehyde 
concentration with activity retention. A maximum activity was 
achieved at 18.5%(w/v) glutaraldehyde solution. Further increase 
in glutaraldehyde concentration did not effectively increase 
activity retention, but the nylon tube turned brown in colour, 
and there was very obvious interaction between samples when the 
enzyme tube was assayed Csee section 6.1.2.5 for explanation 
of the sample interaction effect).
Increasing period of incubation at 90® increased activity 
retention. Fig. 5.2.1.2 illustrates the results obtained 
showing a maximum activity retention at 15 min incubation period.
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Fig. 5.2.1.1 Effect of glutaraldehyde concentration on activity 
retention.
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Fig. 5.2.1.2 Effect of period of incubation on activity retention.
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Longer period of exposure to glutaraldehyde produced brown 
coloured tube with no further increase in activity retention.
Maximum activity retention was achieved when nylon tube 
was incubated at 90°, the maximum temperature studied. The 
relative activity retention at varying temperature is shown 
in Fig, 5.2.1.3.
Fig. 5.2.1.4 shows the effect of pH of glutaraldehyde 
solution in the activation of nylon tube. There seemed to be 
high activation of nylon at both acidic and alkaline pH 
values. High activity enzyme tubes were produced when nylon 
was activated by glutaraldehyde in these pH values. However 
tubes activated by acidic glutaraldehyde solution resulted in 
brown colouration with obvious high sample interaction during 
continuous analysis of samples.
In all conditions studied, protein coupling increased with 
activity retention, but as the absolute concentration of protein 
was not determined, the effect with respect to specific activity 
of enzyme coupled to the activated tube was not presented.
It is worthwhile noting that in assaying the activity 
of enzyme tubes with high sample interactions, the activity 
observed may be higher than it should be. The effect of 
proceeding sample analysed would falsely elevate the subsequent 
sample above its true value.
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Fig. 5.2.1.3 Effect of temperature of activation on activity 
retention.
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Fig. 5.2.1.4 Effect of pH of glutaraldehyde solutions in the
activation of nylon tube. Glutaraldehyde was diluted in citrate (v), 
acetate (v), phosphate (•) and borate (♦) buffers.
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5.2.2 Optimum PEI concentration for spacer coupling to activated 
nylon tube
Nylon tube was O-alkylated as described in section 5.1,1.2 
and substituted with PEI, adipic hydrazide and diaminoethane 
(section 5.1.1.3). GOD was coupled by glutaraldehyde activation
(section 5.1.1.4). Generally it was found that enzyme tube
with adipic hydrazide and diaminoethane spacers retained about 
80% activity retained by enzyme tubes with PEI as spacer.
Nylon tube was activated by 18.5%(w/v) glutaraldehyde 
at 90° for 15 min, and varying concentrations of PEI were used 
for the coupling of spacer to the activated tube (section 5.1.1.2) 
Pig. 5.2.2.1 shows the relative enzyme activity retention of 
these tubes on GOD immobilisation. 10%(w/v) PEI solution 
shows maximum activity retention, this PEI concentration being 
the maximum concentration investigated. Higher concentration 
of PEI coagulated inside the nylon tubes during the coupling 
period (.spacer attachment) and there was difficulty in removal 
of excess unbound PEI.
5.2.3 Comparison between immobilised enzyme derivatives prepared 
from 0-alkylated and glutaraldehyde activated nylon tube
Nylon tube was either 0-alkylated (section 5.1.1.2) or 
directly activated by glutaraldehyde (section 5.1.3). The 
activated nylon tube was attached with PEI as spacer (section 
5.1.1, 5.1.3) and GOD was immobilised to the tube after 
reactivation by glutaraldehyde (section 5.1.1.4).
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Fig. 5.2.2.1 Effect of PEI concentration on activity retention
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Table 5.2.3.1 summarises the result obtained.
0-alkylated enzyme tube has about 70% of the activity retained 
by glutaraldehyde activated nylon tube.
5.2.4 Comparison between glutaraldehyde and bisimidate coupling 
of enzyme to PEI-derivatised nylon tube
Table 5.2.4.1 summarises the result obtained when GOD was 
coupled by glutaraldehyde or bisraidate (section 5.1.1.4).
Nylon tube was activated by glutaraldehyde and attached with 
PEI as spacer (section 5.1.3).
The results show no significant differences in the amount 
of activity and protein retained by either of these methods.
5.2.5 Immobilisation of uricase to nylon tube
5.2.5.1 Immobilisation of uricase to 0-alkylated and 
glutaraldehyde activated nylon tube
Nylon tube was 0-alkylated (section 5.1.1.2) and activated
by glutaraldehyde (section 5.1.3) and the activated tube was
coupled to PEI (section 5.1.1.3, 5.1.4) and uricase was 
immobilised as described in section 5.1.3,
Table 5.2.5.1.1 summarises the result obtained which 
shows that a higher activity enzyme tube is produced with 
glutaraldehyde activation. About twice the activity was 
retained by glutaraldehyde activated tube as there was in 
TOTFB-activated nylon tube.
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5.2.5.2 Immobilisation of uricase to derivatised nylon tube 
by glutaraldehyde and bisimidate coupling
PEI-derivatised nylon tubes were prepared as described in 
section 5,1.3. Glutaraldehyde and bisimidate coupling were 
as described in section 5.1.1.5. Fig. 5.2.5.2.1 summarises 
the data obtained, which shows no particular variation between 
the two coupling agents in the immobilisation of uricase.
5.2.5.3 Immobilisation of uricase to nylon tube using different 
concentrations of uricase in the coupling solution
PEI-derivatised nylon was prepared as described in 
section 5.1.3. Different concentrations of uricase (in 
coupling solutions) were coupled to the tube by glutaraldehyde 
(section 5.1.1.4). A commercial preparation of uricase from 
Candidcz uti-tis was also immobilised as above.
Table 5.2.5.3.1 summarises the results obtained. The 
enzyme tube activity (k^) increased with higher concentration 
of uricase in the coupling solution. Activity retention 
increased with increased concentration of enzyme in coupling 
solution, but it is significant that at the highest concentration 
investigated uricase activity could be detected in the post­
coupling solution.
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5.2.5.4 Immobilisation of uricase to nylon tube in the presence 
of substrate/inhibitor in the coupling solutions
PEI-derivatised nylon tube was prepared as described in
section 5.1.3, and uricase was immobilised by glutaraldehyde 
coupling (section 5,1.1.4).
Table 5.2.5.4.1 summarises the results obtained with different
coupling solutions. Evidently the presence of a substrate/,
inhibitor in the coupling solution improved the percentage 
activity retention. On the basis of the data available, the 
presence of substrate seemed to be more favourable for higher 
activity retention than that of the inhibitor.
5.2.5.5 Determination of Kjji> and k-j/ of immobilised uricase
Immobilised uricase was prepared as described in section
5.1.3, and assayed according to the method described in section
5.1.4.3. Substrate concentrations (urate) in the range of 
0.025 to ImM were used.
a. Effect of air segmentation
Fig. 5.2.5.5.1 shows the relationship between FSq and ln(l - F> 
in the presence and absence of air-segmentation in the substrate 
flow through the enzyme tube. Two buffers were used in the 
studies; i.e. 50mM borate, O.IM NaCl pH 8.6, and 50mM glycrr^z 
O.IM NaCl pH 9.0.
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Significantly, was higher in "glycine buffer and when the 
uricase tube was assayed with air-segmentations in the substrate 
flow. The Km' values were similar in all cases except when the 
immobilised enzyme was assayed in glycine buffer without air- 
segmentation in the substrate flow. Table 5.2.5.5.1 summarises 
the values of and k^ ' obtained from the plot.
b. Effect of ionic concentration
Fig. 5.2.5.5.2 shows the relationship between FSq and 
In Cl - F) for different ionic buffer strengths. Linear 
plots were obtained with buffers containing NaCl. There was 
some variations in the values of k^ obtained with different 
buffer systems used. Table 5.2.5.5.2 shows the values of 
kt* and Km» obtained from the plot.
c. Effect of flow rate
Fig. 5.2.5.5,3 shows the relationship between FSq and 
In Cl - F) with different flow rates of substrate through the 
enzyme tube. Table 5.2.5.5.3 shows the values of Km» and 
k.^  obtained from this plot.
There seemed to be an increase in k^  ^values with higher 
flow rates, but there appeared to be no variation in the values 
of Km' .
The variation of k^ with flow rate was also studied by 
calculating k^ using the formula k^L = ”  (section 5.1.4.1b).
A plot of percentage of oxygen consumption in relation to flow 
rate and k.^/ is shown in Fig. 5.2.5.5.4,
Buffer systems
Without air- 
segmentation
With air- 
segmentation
Km'
Cx 10%)
%t'
(U.m-1)
Km'
(X 10%)
%t'
(U.m-1)
50mM borate, O.IM 
NaCl pH 8.6 4.1 0.24 4.3 0.34
50mM glycine, O.IM 
NaCl pH 9.0 8.4 0.28 4.3 0.36
Table 5.2.5.5,1 K^»and values obtained when assayed
with and without air-segmentation in the substrate flow. 
These values were obtained from the graph shown in 
Fig. 5.2.5.5.1.
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Fig. 5.2.5.5.1 Relationship between FSq and ln(l - F) with
and without air segmentation in substrate flow during assay 
(section 5.2.5.5a). Flow rate was 1.4 ml.min"^. Enzyme tube 
CIO cm) was assayed with urate in borate buffer pH 8.6, 
without air-segmentation (v), with air segmentation (O) and in 
glycine buffer pH 9.0 without air-segmentation (v) and with air 
segmentation (♦).
Buffer systems Km-
(X 10%)
kt*
(U.m-1)
50mM glycine pH 9.0 - 0.28
SOraM glycine pH 9.0 
with O.IM NaCl 4.1 0.36
50mM glycine pH 9.0 
with 0.5M NaCl 5.8 0.34
SOmM borate pH 8.6 
with O.IM NaCl 4.5 0.34
Table 5.2.5.5,2 Variation in and with ionic
strengths. The values were calculated from the 
plots on Fig. 5.2.5.5.2.
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Pig. 5,2.5.5.2 Relationship between FS^ and ln(l - F) with 
different ionic strengths. Enzyme tube (10 cm) was assayed 
with urate dissolved in the following buffers; 50mM glycine 
pH 9.Ô CO) / SOmM glycine, O.IM NaCl pH 9.0 (♦) , 50 mM glycine 
C0.5M NaCl pH 9.0 (y) and SOmM borate, O.IM NaCl pH 8.6 (^ ) . 
Flow rate was 1.4 ml.min” .^
Flow rate Km* %t'
(ml.min” ) (X lO^M) (U.m” l)
1.4 3.8 0.37
2.0 3.9 0.40
2.4 4.0 0.43
Table 5.2.5.5.3 Variation in K^,.and values
with different flow rates. The values were calculated
from the plots of Fig. 5.2.5.5.3.
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Fig. 5.2.5.5.3 Relationship between FS^ and ln(l - F) with 
different flow rates. The flow was air-segmented and the 
substrate dissolved in SOmM glycine, O.IM NaCl pH 9.0.
The flow rate investigated was 1.4 ml.min"^ (♦) , 2.0 ml.min"- (▼}
and 2.4 ml.min (•) .
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Fig. 5.2.5.5.4 in relation to the flow rates and
percentage of oxygen conversion, where ktL= ^  (section 5.1.4.1b) 
CO) denoted k^ and (^ ) denoted percentage oxygen conversion.
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5.2.5.5 pH profile of immobilised uricase
Immobilised uricase was assayed in a range of pH values, 
and the tube activity (k^) assayed (section 5.1.4.1b).
The range of pH of 7.6 to 10.0 was studied, with O.IM 
TRIS-HCl (O.IM with respect to NaCl), and SOmM borate 
CO.IM with respect to NaCl), used over the range of pH values.
Fig. 5.2.5,6.1 shows the pH profile of immobilised uricase with 
the precentage maximum activity plotted against pH. Optimum 
pH for the immobilised uricase was observed to be in the range
9.0 - 9.2.
5.2.5.7 Thermal dénaturation of immobilised uricase
Immobilised uricase tubes were prepared (section 5.1.3) 
and the activity assayed (section 5.1.4.3). k^ was calculated 
according to section 5.1.4.1b. .
Enzyme tubes (10 cm) were assayed for activity, and incubated 
in a series of buffer at 37° for set period of incubation.
After the incubation period the tubes were immersed in ice-cold 
buffer, and then assayed for residual activity. Fig. 5,2.5,7.1 
shows the residual activity plotted against incubation periods 
for different buffer systems. Significantly there was low 
thermal resistance by the immobilised uricase when the tube was 
incubated in borate buffer, and there appeared to be greater 
dénaturation of enzyme when the tube was incubated in high, pH 
buffer. The use of high ionic concentration in the buffer die 
not alter the dénaturation characteristics of the immobilised 
uricase.
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Pig. 5.2.5,6.1 pH profile of immobilised uricase. The range
of pH was studied in TRIS-HCl (♦) and borate (▼) buffers.
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Fig. 5.2.5.7.1 Stability of immobilised uricase tube at 37° 
in O.IM glycine pH 9.0 O  t SOmM glycine, 0.2M NaCl, 0.05% 
Triton XlOO pH 9.0 (O), O.lM borate pH 9.0 (#), O.IM borate 
pH 10.0 (#) , O.IM borate, 0.2M NaCl pH 9.0 (T) and O.IM borate, 
0.5M NaCl pH 9.0 (v).
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Fig. 5,2.5.7.2 shows the residual activity of the enzyme 
derivatives incubated in 50mM glycine, 0.2M NaCl and
0.05%(w/v) Triton XlOO pH 10 under different incubation 
temperatures.
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Fig. 5.2.5.7.2 Stability of immobilised uricase tube 
incubated in SOmM glycine, 0.2M NaCl, 0.05% Triton XlOO 
pH 9.0 at 37= (O) , 45= (♦) , 50= (#), 55= (v) and 60= (v) .
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5,3 Discussion
The method of direct activation of nylon tube by glutaraldehyde 
described in this work allows the generation of reactive centres 
on the nylon tube for enzyme immobilisation, using an easily 
available reagent. The conditions for activation are fairly 
mild and controllable.
The results suggest that the number of reactive centres 
increases with both time and temperature of exposure to 
glutaraldehyde solutions. Higher concentration of glutaraldehyde 
also generated more reactive centres, but the use of undiluted 
commercial preparations of glutaraldehyde, (25%,w/v), produced 
unsuitable tubes for enzyme immobilisation (when the ultimate use 
of these enzyme tubes were considered). Possibly the commercial 
preparation is unbuffered and the low pH contributes to an 
uncontrolled reaction on the nylon surface. Similar occurrence 
was observed when nylon tubes were activated by low pH glutaraldehyde 
solutions. This deterioration in the nylon tube may be due to 
simultaneous activation of nylon polymer by acid hydrolysis (87).
The chemistry of glutaraldehyde activation is very uncertain.
It is notable that in this work glutaraldehyde was utilised twice, 
firstly to activate the nylon tube, and secondly to couple the 
enzyme to amine- or hydrazide-substituted nylon tube, with the 
conditions of reactions not exactly similar. High temperature 
was a feature in the activation procedure whereas the coupling
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reactions were carried out at low temperatures. Onyezili (128) 
showed that enzyme immobilisation was in fact independent of 
temperature during the glutaraldehyde-mediated coupling. Whipple 
and Ruta (.96) showed that the composition of an aqueous solution 
of glutaraldehyde was dependent on the temperature. Apparently 
the percentage of free aldehyde rose from 4% at 23° to about 
70% at 70°. Presumably at 90° there is a high percentage of 
free aldehyde that can be involved in the activation reaction. 
However, the presence of polyglutaraldehyde in the alkaline 
solution cannot be discounted (98), though its variation with 
temperature is unknown. Under the circumstances, no conclusion 
can be made on the mechanism of glutaraldehyde reaction but the 
versatility of this bifunctional agent is clearly supported 
thus explaining its increasing use in this field.
Significantly higher activity enzyme tubes were produced 
using glutaraldehyde-activated nylon tubes as compared to those 
using TOTFB-activated nylon tubes. This trend was observed with 
either immobilised glucose oxidase or uricase. Apparently 
glutaraldehyde produced more reactive centres for spacers 
attachment, and eventually enzyme immobilisation. Obviously, 
this conclusion could not be made solely on the basis of activity 
retention. However, protein coupling data seemed to substantiate 
this point. No significant difference was observed when enzymes 
were immobilised by glutaraldehyde or bisimidate coupling, judging 
by the percentage of activity retention. Glutaraldehyde can ceaci 
with a wider variety of chemical groups and may effect more enzyne 
coupling, but the randomness of the reactive groups used in the
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coupling may deactivate some of the immobilised enzyme molecules. 
Imidate essentially reacts with the free amino groups in the 
protein molecules and may cause less dénaturation. However the 
effectiveness of a particular method of activation or coupling 
may not necessarily depend on the number of reactive centres 
generated or the number of enzyme molecules coupled, but rather 
on the final activity retained on immobilisation. This factor 
may be finally influenced by the suitability of the particular 
environment created for the particular enzyme molecule.
The use of PEI as a spacer between the nylon support and the 
enzyme molecules may increase the number of potentially reactive 
groups for each reactive centre generated by glutaraldehyde 
activation of nylon tube. PEI is a highly branched polymer 
of large molecular weight (> 20,000). Its repeating unit is 
believed to be of the type;
- N - CH2 - CH2 CNH - CH2 - CH2)n - NH2
The structure may be sufficiently compact to form a protective 
coat along the surface of the nylon tube, with free amino groups 
for enzyme immobilisation. Campbell et al. (90) showed that 
glucose oxidase was more active when immobilised to nylon tube 
with diaminohexahe and lysine spacers than that with PEI spacer, 
a fact attributed to the lability of PEI in alkaline solution.
It was shown here that coupling of PEI in water proved to be 
more useful.
1
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There was about 20% retention of activity on immobilisation 
of uricase, and the tendency would be a decrease in percentage 
of activity retention with increasing concentration of enzyme 
in the coupling solution, a fact observed by Gray al. (131) 
when immobilising g-glucosidase onto cellulose. Onyezili (128) 
showed that higher concentration of invertase resulted in a 
decrease in specific activity of enzyme coupled to nylon tube.
No increase in total activity was achieved after a certain protein 
concentration. The amount of protein immobilised may be limited 
by the number of reactive centres available for coupling, but 
the total activity retention may be influenced by crowding effect 
of enzyme molecules. Hinberg and Driscoll (132) obtained 47% 
activity retention but the method of gel entrapment used is 
generally less destructive to enzyme molecules. Similarly,
Suzuki efc al. (133) obtained 43% retention of activity when 
uricase was electrochemically entrapped in collagen membrane. 
However, chemical coupling of the enzyme resulted in a lower 
activity retention as shown by Broun et al. (134) where 5-30% 
of uricase activity was retained when the enzyme was immobilised 
to protein membranes or porous particles by glutaraldehyde 
crosslinking. Gray et al. (131) achieved 18% retention of 
uricase activity when uricase was immobilised to cellulose by 
diazo coupling.
Paillot et al. (135) only achieved a 2% retention of uricase 
activity when the enzyme was coupled to inert protein by 
glutaraldehyde, but this activity retained increased to 12%
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when uric acid was added to the coupling mixture; a result which 
the present work substantiated. Obviously uric acid and 
oxonate protect the active sites of the enzyme during coupling. 
Incidentally, Paillot et a^. also showed that the protective 
property of urate was further enhanced when the coupling mixture 
was deprived of oxygen, the co-substrate of uricase.
It is interesting to note that the percentage of activity 
retention was similar for glucose oxidase and uricase on immobilisation 
to nylon tube. Though the enzymes appear to catalyse similar 
reactions, the enzyme molecules are dissimilar in size and 
conformation (?). However, there is the possibility that both 
enzymes are similarly affected by the nylon polymer and method 
of immobilisation.
The validity of the integrated Michaelis-Menten equation,
FSo = Km'lnCl - F) + ktLQ-1
was investigated in the assay of immobilised uricase. The 
plots of FSo against ln(l - F) were linear within the range 
of substrate used. In order that the equation is to be 
applicable under the assay conditions studied, K^, and k^f 
would have to be independent of the flow rate Q, and the initial 
substrate concentration, Sq . Though there was no discernible 
effect of Sq in these experiments, there were some small variations 
in k-t with ionic strength and flow rate. The variation due to 
ionic strength showed no particular trend with data available here.
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However, there was an apparent decrease in with decreased 
flow rate.
The variation in K^i was less distinct, in fact almost 
negligible.. The obtained was about 4 times that of the 
soluble enzyme. Hinberg and Driscoll (132) obtained a 
for gel entrapped uricase which was about 3 times that of the 
soluble uricase, but Keys and Semersky (136) showed similar values 
of Kjq for soluble uricase and uricase immobilised to agarose 
beads.
The use of short enzyme tubes may have reduced the diffusion 
effect, which is more prominent in packed bed reactors (137) .
The presence of air segmentation may also reduce the diffusion 
effect, but on the other hand may also affect the values of Kjn« 
and k^ as it may determine the dissolved concentration of 
oxygen in the assay solution. Hornby e^ a^. (107) showed that 
the K^ and Vmax of glucose oxidase immobilised to polystyrene 
tubes increased 2 fold if the enzyme tubes were assayed with 
oxygen-segmented substrate flow instead of air-segmented substrate 
flow.
It is noticeable that in Fig. 5.2.5.5.4, the plot of 
percentage O2 consumed against flow rate is generally in the 
trend expected for the Michaelis-Menton equation. Theoretically 
the : fraction. • . of oxygen consumed would be equal to 1 when Q is 
zero, and would asymptote when Q tends to «.
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Uricase immobilised to nylon tube has a pH optimum of 
9.0-9.2. There seemed to be a slight alkaline shift on the 
pH profile of the immobilised uricase when compared to the 
soluble enzyme profile. Hinberg and Driscoll (132) found a 
similar but more pronounced shift in pH optimum (from 8.6 to 
9.6), however uricase entrapped in collagen membrane showed 
an identical pH profile to the soluble enzyme (133). This 
difference in pH optimum may be attributed to the absence or 
presence of charges on the support materials.
Uricase immobilised to nylon tube was less stable to heat 
than its soluble counterpart when incubated in borate buffer, 
a fact also pointed out by McCarthy and Johnson (138) when studying 
uricase immobilised to elastin. Immobilised uricase incubated 
in glycine buffer showed more resistance to heat, comparable with 
the soluble enzyme. Uricase immobilised to elastin also showed 
comparable resistance to heat when incubated in TRIS-HCl buffer 
(138). Apparently TRIS and glycine have some protective 
properties with respect to the immobilised uricase molecules.
It was also found that incubation at higher pH in borate buffer 
further enhanced the dénaturation of the immobilised enzyme.
Paillot et (.135) achieved a better stability when uricase was
crosslinked to albumin, showing that albumin could give the enzyme 
molecules some kind of protection.
The immobilised enzyme was found to be fairly stable at 37° 
when incubated in glycine buffer. The presence of NaCl and 
Triton XlOO in this buffer, showed no observable effect on the
160
stability. This is significant in view of its use in the 
analysis of urate (section 6).
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6. DEVELOPMENT OF A SYSTEM FOR THE USE OF IMMOBILISED 
URICASE IN AUTOMATED ANALYSIS
Uricase immobilised to nylon tube was incorporated into 
a continuous flow analyser (Technicon AutoAnalyser AAl). 
Hydrogen peroxide produced in the uricase catalysed reaction 
(equation 1) was reacted with'two oxidative reactants, 4-amino- 
phenazone (APZ) and dichlorohydroxyl benzoyl sulphonate (HBS), 
in the presence of peroxidase (POD) (equation 2).
Uric acid + O 2 + H 2O — allantoin + CO2 + H 2O 2 1 
H 2O 2 + APZ + HBS ------- > quinone dye + H 2O 2
The coloured product was monitored at 505nm, intensity of 
colour produced being a measure of urate concentration.
6.1 Methods
6.1.1 Optimisation of colour reagents 
Reagents
1. Working buffer; SOmM glycine, pH 9.0, containing 0.2M 
NaCl and 0.05%(w/v) Triton XlOO-
2. Reagent A: HBS; varying concentrations of HBS were dissolved 
in 0.2M phosphate pH 7.0.
3. Reagent B: APZ-POD; varying amounts of APZ and POD were 
dissolved in 0.2M phosphate pH 7.0.
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4. Hydrogen peroxide standard; 0-0.25itiM.
The flow system used for these studies is. as shown in
Pig.55.2.1.1, without the inclusion of the enzyme tube.
Keys to the flow system
Pumping line Flow rate (ml.min~^)
1. Air 0.8
2. Buffer 2.0
3. Sample 0.23
4. Reagent A 0,23
5. Reagent B 0.23
6. Wash line, (buffer) 1.0
7. Flow cell 2.5
Sampling rate was 60 samples h~^ with 2:1 sample to wash 
ratio. All mixing coils (MC) were maintained at 37°,
5.1.2 The use of immobilised uricase in automated analysis 
Reagents
1. Standard urate solutions
50 mg uric acid and 40 mg lithium carbonate were dissolved 
in warm distilled water (60°), cooled and made to 100 ml.
Standard urate solutions, 2-20 mg.100 ml"*^, were made by
diluting the stock solution accordingly with distilled water,
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2. Buffer solution (working buffer)
50mM glycine, pH 9.0, containing 0.2M NaCl and 0.05%(v/v) 
Triton XlOO.
3. Reagent A. HBS, 10 rng.ml"^ in 0.2M phosphate pH 7.0.
4. Reagent B. APZ, 0.6 mg.ml""^, and POD, 0.05 mg.ml*"^ 
in 0.2M phosphate pH 7,0.
5. Immobilised uricase tube; as prepared in section 5.1.3. 
Procedure
The flow system used for the incorporation of immobilised 
uricase in automated analysis is as shown in Fig. 6.1.2.1. The 
system comprised solely the AutoAnalyser AAl modules (Technicon)
Samples were automatically and continuously drawn into the 
continuous flow system and analysed. Working buffer was drawn 
between samples, to wash the sampling line.
6.1,2.1 Stability of immobilised uricase
a. Operational
2m immobilised uricase tube was incorporated into the flow 
system (Fig. 6.1.2.1).
Sairqples were prepared by adding stock urate solution to 
bovine serum (These samples were used as human serum was not 
easily available). Samples in the range of 1.5-10 mg urate.
I
Keys to Fig. 6,1.2.1
Pumping line Flow rate (ml.min” )^
1. Air 0.8
2. Buffer 2.0
3. Samples 0.23
4. Air 0.8
5. Buffer 2.0
6. Buffer 0.23
7. Reagent A 0.23
8. Reagent A 0.23
9. Wash line 1.0
10. Flow cell 2.5
MC - mixing coils 
ET - enzyme tube
The dialyser and mixing coils were maintained at 37°
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Fig. 6.1.2.1 Flow system for the incorporation of 
immobilised uricase tube in the automated analysis 
of urate.
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100 ml-^ were assayed randomly at 60 samples h” .^ A total of 
1500 samples were assayed continuously.
Batches of 10 to 50 samples were assayed over a period of 
3 months by a single tube of immobilised uricase. The enzyme 
tube was stored at 4® with working buffer (when not in use).
A total of 5000 samples were assayed.
b. Storage
i. Cold storage at 4°
2m uricase tubes were filled with working buffer and stored 
at 4®. The stability of these tubes was monitored by assaying 
standard solutions of uric acid.
ii. Room temperature
2m uricase tubes were filled with working buffer and kept on 
the bench at room -temperature. The stability of the tubes 
were monitored by assaying standard urate solutions.
6.1.2.2 Precision 
Reagents
1. Serum specimens. Samples were prepared by adding stock 
urate solution to bovine serum.
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Procedure
25 specimens for each of three urate levels were randomly 
and continuously assayed on the analyser (Fig. 6.1.2.1) using 
2m immobilised uricase tube. The deviations from the mean 
values were calculated. The coefficient of variation (C.V.) 
for each levels of urate gave a measure or precision.
_ „ Standard deviationC.V. = --------------------  X 100mean
6.1.2.3 Recovery 
Procedure
Immobilised uricase tube (2m) was incorporated into the 
analyser (Fig. 6.1.2.1).
Known quantities of stock urate solution were added to pooled 
serum. The calculated values were compared with values obtained 
by the immobilised enzyme method. Calibration plots were obtained 
using standard urate solutions with and without 7% albumin,
6.1.2.4 Carry-over studies
Carry-over studies were carried out according to the scheme 
put forward by Broughton et (139) .
Reagent
1. Serum specimens; Samples were prepared by adding stock 
urate solution to bovine serum.
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Procedure
Carry-over studies were carried out on the flow system 
shown in Fig. 6 .1.2.1, with 2m uricase tube incorporated into 
the analyser.
The analysis was carried out by continuously sampling two 
levels of urate, proceeding with the higher level (3 specimens) 
followed by the lower level (3 specimens). If the specimens 
with the high urate level were Ai,A2 /A3 and the specimens with 
the low urate levels were B 2 , B 3 , and the recorded values 
of the analyser were a%, a2  ^ as, bj, b 2 / bs, then the carry-over 
between the two samples was given as
K = ~ *"3as - bs
where, K - carry-over constant.
bs was assumed as the 'true' value of specimen B since it was 
proceeded by 2 samples of equal concentration and thus the 
carry-over was negligible.
The carry-over characteristics were also studied with 
respect to the constituents of the working buffer. Variation 
in NaCl content and the concentration of Triton XlOO were used 
to investigate their effect on sample interactions.
6 .1.2.5 Interference
The presence of certain substances in serum may affect the 
accuracy of urate measurement. A few common substances found
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in serum were studied for any interfering effect in the analysis 
of urate.
Procedure
Known quantities of ascorbic acid, cysteine, glutathione, 
albumin and glucose were added to standard urate solutions with 
and without 7% albumin.
The samples were assayed on the system described in 
Fig. 6.1.2.1, using 2m uricase tube.
6.1.2.6 Correlation
The viability of using the method in routine analysis 
was further investigated by comparing this method with an 
accepted method. Serum specimens were assayed by both methods 
and the data compared.
Procedure
Serum specimens were assayed by a soluble automated method 
on the DU PONT Automatic Clinical Analyser adapted from the method 
developed by Henry (25). The concentration of urate was 
monitored by its absorbance at 293nm. These assays were carried 
out at the Ninewells Hospital, Dundee.
These serum specimens were then assayed by the immobilised 
uricase method using the flow system shown in Fig. 6.1.2.1 with 
2m immobilised uricase incorporated into the system.
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As it was the practice of the Ninewells Hospital to assay 
a single batch of specimens weekly, the studies were carried 
out over a period of 4 weeks. Four batches of specimens 
totalling 64 specimens were assayed.
Wellcomtrol serums (Wellcome) were also assayed on the 
immobilised uricase system and the values obtained compared 
with the manufacturer's data.
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6.2 Results
6.2.1 Optimum conditions for product measurement
The flow system used for these studies is as described in
section 6.1,1. Absorptions at 505nm were monitored by assaying 
standard solutions of hydrogen peroxide and plotting a series of 
calibration curves.
6.2.1.1 Optimum HBS concentration
The concentration of HBS (reagent A) was varied (1 - 12 mg.ml~^ 
in 0.2M phosphate buffer pH 7.0). The upper concentration studied 
was limited by the solubility of HBS in the buffer. The 
composition of reagent B was kept at 0.6 mg APZ.ml"^ and 0.02 mg 
POD.ml” .^ Fig. 6.2.1.1.1 shows the calibration plots obtained, 
with the highest absorption achieved at 12 mg HBS.ml“ .^
6.2.1.2 Optimum APZ concentration
The concentration of APZ was varied (0.1 - 5.0 mg.ml"’^ )
with the concentration of POD kept constant (0.02 mg.ml""^) . The
concentration of reagent A was maintained at 12 mg HBS.ml” .^
Fig. 6.2.1.2.1 shows the results obtained. Colour development 
was optimal at APZ concentration of 0.3 - 0.6 mg.ml“  ^ with higher 
concentrations of APZ causing a depression in the colour development.
6.2.1.3 Optimum POD concentration
Fig. 6.2.1.3.1 shows the results obtained when the hydrcrer. 
peroxide standard solutions were assayed with different concentratiori
■ ift:
Fig. 6.2.1.1.1 Calibration plots for different concentrations 
of HBS. The concentrations of HBS used were 1 mg.ml” Mo) ,
2 mg.ml“ ^(v), 6 mg.ml*"^ (♦) , 10 mg.ml"^ (▼) and 12 mg.ml”  ^(•) .
Fig. 6.2.1.2.1 Calibration plots for different concentrations 
of APZ. Plots are for APZ concentration of 0.1 mg.ml"^(v) ,
0.5 mg.ml"l(#) and 1.0 m g . m l ” ^ ( A )  and 5.0 mg.ml“  ^(O).
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of POD (0.005 - 1.0 mg.ml"^) . APZ concentration was maintained 
at 0.6 mg.ml-1, and the HBS concentration was kept constant at 
12 mg.ml"'^. No increase in colour development was observed 
at POD concentration higher than 0.02’ing.ml”^.
6.2.1.4 Buffer used in the flow system
Borate buffer was considered as an alternative working 
buffer for use in the flow system. SOmfl borate pH 9.0, 
containing 0.2M NaCl and 0.05%(v/v) Triton XlOO was used.
Fig. 6.2.1.4.1 shows the calibration plots obtained with 
the two buffer systems. There was better colour development 
when standard hydrogen peroxide solutions were assayed in glycine 
buffer. Although the difference was small, it was consistently 
obtained.
6.3.3 Comparison between the HBS-APZ reagent and Trinder's reagent
For the HBS-APZ reagent, 12 mg HBS.ml” ,^ 0.6 mg APZ.ml""^ 
and 0'02mg POD.ml"^ were used, while Trinder's reagent was as 
described in section 5.1.2.1.
The results are presented in Fig. 6.2.2.1 which clearly 
shows the increased sensitivity of the HBS-APZ reagent (about 
3 fold).
Fig. 6.2.1.3.1 Calibration plots for different concentrations 
of POD. The plots are for POD concentration of 0.005 mg.ml"^(v) , 
0.01 mg.ml~l(v) and 0.02 mg.ml”^ (•),
Fig. 6.2.1.4.1 Calibration plots using two different buffer 
systems. The buffers used were borate (♦) and glycine (•).
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Fig. 6.2.2.1 Calibration plots obtained with different 
chromogens for the colour-forming reactions. HBS-APZ 
reagent (•) and Trinder's reagent (▼) were used for 
comparison of sensitivity.
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5.2.3 Use of immobilised urlease in analysis
6.2.3.1 Calibrations of analytical system
Immobilised uricase tubes .were incorporated into the flow 
system shown in Pig. 6.1.2.1 and standard solutions of urate 
assayed as described in section 6.1.2. Fig. 6.2.3.1.1 shows a 
typical calibration plot of standard solutions of urate, when 
2m immobilised uricase tube was incorporated into the analyser. 
This kind of calibration plot was used for determination of 
urate levels in serum.
Fig. 6.2.3.1.2 shows calibration plots obtained when uricase 
tube with different activity (k^) were incorporated into the 
analyser.
Fig. 6.2.3.1.3 shows a series of plots obtained when 0.5,
0.1 and 2m of a particular uricase tube were used to assay 
standard urate solutions.
Fig. 6.2.3.1.4a, b shows typical recorder outputs on 
assaying standard urate solutions.
6.2.3.2 Stability of immobilised uricase
a. Operational
Operational stability of uricase was monitored as described 
in section 6.1.2.1a. After assaying 1500 serum samples 
continuously, no change in the calibration plot was observed.
LU 0 4
w 03
URATE (mg-lOOml"')
Pig. 6.2.3.1.1 Calibration plot for determination of urate 
levels in serum. Standard solutions of urate were assayed at 
the rate of 40 s a m p l e s . .
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Calibration plots obtained by using uricase
tubes of different activities. values of the enzyme tubes
were 0.39 U.m“l (•) , 0.35 U.m“  ^(▼) , 0.23 U.ml^MO) . and 0.11 U.m
For further details of the different tubes used, see
Table 5.2.5.3.1.
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Fig. 6.2.3.1.3 Calibration plots obtained by using different
lengths of ah immobilised enzyme tube.
and 2.0m (•) lengths of the uricase tube were used.
Fig. 6.2,3.1.4a Data presentation for automated analysis 
of urate using immobilised uricase. The above figure shows 
the recorder output when standard solutions were assayed, 
at 40 samples h.~^ with 2:1 sample to wash ratio.
2 a m
JEL
Pig. 6.2.3.1.4b Data presentation for automated analysis of 
urate using immobilised uricase. The figure shows the recorder 
output when standard solutions of urate were assayed, at 
60 samples h”  ^ with 2:1 sample to wash ratio. .
zn
JJOl
I
181
Fig. 6.2.3.2.1 shows the changes in the calibration plots 
over a period of 90 days with intermittent use of the immobilised 
uricase tube, during which a total of 5000 serum samples were 
assayed.
b . Storage
i. Cold storage at 4°
Pig. 6.2.3.2.2 shows the calibration plots obtained with 
enzyme tubes stored at 4® over a period of 90 days. Although 
there was apparent decrease in activity the calibration plots 
were linear within this period.
ii. At room temperature
Fig. 6.2.3.2.3 shows the calibration plots obtained with 
enzyme tubes e^osed to room temperature. The plots seemed 
to be linear up to 14 days, after which the activity loss was 
sufficiently large to affect the linearity of the calibration 
plots.
6.2.3.3 Precision studies
The precision of this analytical system was studied and 
the results summarised in Table 6.2.3.3.1. Overall, the urate 
levels obtained showed a higher mean value when the serum 
specimens were assayed at the higher sampling rate. The 
increase in mean values may be attributed to the false increase 
in readings due to sample interactions (section 5.2.3.5).
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Fig. 6.2.3.2.1 Operational stability of immobilised uricase.
Intermittent assay of serum specimens were carried out, and the 
enzyme tube stored at 4® when not in use. The calibration 
plots were obtained after 0-14 days {•), 45 days (▼), 60 days (#> , 
and 90 days (O) •
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Storage stability of immobilised uricase at 4®,
The immobilised uricase tubes were assayed initially and
after 30 days (#), 60 days (T) and 90 days «>).
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Fig. 6.2.3.2.3 Storage stability of immobilised uricase at
room temperature. Uricase tubes were assayed initially (#) 
and after 2 days (v)  ^ 7 days (^ ) , 14 days iO) , 30 days (O) 
and 50 days (A) . -
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Sampling rate: 60 samples.h - 1
Mean
Standard
deviation
Coefficient of 
variation
2.416 0.116 4,8
4.570 0.106 2.3
10.104 0.203 2.0
Sairpling rate: 40 samples.h ^
Mean
Standard
deviation
Coefficient of 
variation
2.308 0.081 3.5
4.528 0.102 2.25
10.092 0.076 0.75
Table 6.2.3.3.1 Precision data for the analysis of urate by
the immobilised uricase method. A 2:1 sample to wash ratio
was used for both rates of sampling. The urate values are in
mg.100ml"^ . For further details of this study see section 6.1.2.2.
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This characteristic was further demonstrated by the higher values 
of standard deviations obtained with a higher sampling rate. 
Increase in standard deviations were sufficiently high to cause 
an increase in the coefficient of variations (C.V.). However, 
the coefficient of variations obtained at both sampling rates 
were still less than 5% for all three urate levels investigated.
6.2.3.4 Recovery
The recovery of urate added to samples was studied. Stock 
solution of urate was added to pooled serum, and the total urate 
assayed by the immobilised uricase system compared with total 
urate available (by calculation). The results were calculated 
by using two calibration plots, one using protein-free standard 
solutions of urate and another using standard urate solutions 
containing 7% albumin.
The results summarised in Table 6.2.3.4.1 show virtually 
100% recovery of urate when the -system was calibrated with 
protein-free standard solutions, and 99% recovery when using 
standard solutions with 7% albumin.
Serum 
samples 
mg.100ml"^
Urate Total
%
Recovery
added 
mg.100ml"^
calculated 
m g .100ml"^
assayed 
m g .100ml"^
4.5 2.29 6.79 6.8 100.1
4.5 3.2 7.7 7.8 101.2
5.4 2.29 7.69 7.7 100.2
5.4 3.2 8.6 8.7 101.2
Average recovery - 100.7
A: Calibration with protein-free standard solutions
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Serum Urate Total
samples * 
mg.100ml"
added 
mg.100ml"
calculated 
mg.100ml"
assayed 
mg.100ml"
%
Recovery
4.4 2.29 6.69 6.6 98.6
4.4 3.2 7.6 7.6 100.0
5.4 2.29 7.69 7.6 98.8
5.4 3.2 8.6 8.5 98.8
Average recovery - 99.1
B: Calibration with urate standard solutions containing 7%
albumin.
Table 6.2.3.4.1 Recovery data obtained from the immobilised 
uricase method. (*) assayed by the immobilised uricase method. 
Each assayed value was the average of 4 determinations.
6.2.3.5 Carry-over studies
Carry-over characteristics of the system were investigated 
as described in section 5.1.2,4.
Fig. 6.2.3.5.1 illustrates a typical recorder output for 
these studies.
The carry-over coefficients for•sampling rate of 40 and 
60 h“  ^ were, obtained with urate samples of 10 mg.l00ral“  ^ and
2 mg. 100ml" Table 6.2.3.5.1 summarises the results obtained
Fig, 6,2.3.5.1 Recorder output for the studies of carry-over 
characteristic of the analytical system. The figure shows the 
output for standard urate solutions, followed by 6 urate samples. 
See section 6.1.2.4 for details.
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Sampling rate (h” )^ Carry-over coefficient (K)
40 1.27
60 2.5
Table 6.2.3.5.1 Carry-over coefficient at different sampling 
rates. Each value was the average of 3 determinations.
The concentrations of NaCl and Triton XlOO in the working 
buffer were varied and the carry-over characteristics were 
studied by calculating the carry-over coefficient under the 
conditions studied.
Table 6.2.3.5.2 summarises the results obtained.
NaCl (M) Carry-over coefficient (K)
0.1 1.5
0.2 1.25
0.3 1.24
0.4 1.05
0.5 1.1
A: Effect of varying NaCl concentration in the working buffer,
The concentration of Triton XlOO was maintained at 0.05%(v/v).
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Triton XlOO (%,v/v) Carry-over coefficient (K)
0.001 1.37
0.025 1.17
0.05 1.16
0.1 1.16
B: Effect of varying concentration of Triton XlOO in the
working buffer. 0.2M NaCl was maintained in the buffer.
Table 6.2.3.5.2 Carry-over coefficients in the presence of
different concentrations of NaCl and Triton XlOO in the working 
buffer. Each K value was the average of 3 determinations.
Sampling rate; 40h*‘ .^
From Table 6.2.3.5.2, it can be seen that in the concentration 
range studied, the carry-over coefficients showed little variation. 
It was observed however that in the total absence of NaCl, there 
was^ very high sample interaction (K varied from 30 to 50) . 
Significantly, there was also much reduced dialysis efficiency.
The amount of urate dialysed varied but generally was less than 
50% of maximum efficiency. It was observed that in the presence 
of 0.4M and 0.5M NaCl, a slight depression in absorbance was 
obtained (a decrease of about 5% of maximum absorbance).
In the total absence of Triton XlOO (but in the presence 
of 0.2M NaCl) the carry-over coefficient was still fairly low 
(approximately 1.5). However, there was an apparent effect 
on the efficiency of dialysis. The urate dialysed may be
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reduced to about 70% of maximum efficiency, but this effect 
was not consistently observed.
6.2.3.6 Interference
The effect of certain compounds on the 'true' levels of 
urate in serum was studied (section 6.1.2.5) and the results 
summarised in Table 6.2.3.6.1.
Substance
added
Concentration 
m g .100ml"^
Urate 
(protein- 
free- 
mg.100ml"!
%
Urate 
(7% albumin) 
mg.100ml”!
%
- - 5 100 - -
L-ascorbic 2 3.8 76 4.8 96
acid 5 3.2 64 3.6 73
L-cysteine 5 4.8 96 5.0 100
L-glutath-
ione 5 4.6 92 5.0 100
Albumin 7000 5.15 103 - -
Glucose 300 5 100 5.05 101
- 10 100
L-ascorbic 2 9.6 96
acid 5 8.3 83
Albumin 10.1 100.1
Table 6.3.3.6.1 Interference effect of some substances in the 
assay of urate by the immobilised uricase method. Each value is 
the average of 4 determinations.
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6.2.3.7 Correlation studies
The studies were carried out as described in section 6.1.2.6 
The data obtained from the present method and the reference 
method yielded the linear regression equation,
y = l.Ollx - 0.046
where the correlation coefficient, r = 0.984, y = 5.584,
X = 5.567, (bias = 0.3%) for 64 serum specimens over the range 
of 1.5 - 10.8 mg urate.100ml"!.
Fig,6.2.3.7.1 shows the data obtained from the two methods.
Table 6.2.3.7.1 shows the values obtained when control 
serum were assayed on the immobilised uricase system. The 
results show, in general, lower values of urate obtained by the 
present method.
Wellcomtrol serum
Manufacturer’s data 
mg.100ml"!
Immobilised 
uricase method 
mg.100ml"!
No : 1 5.6 5.15
No: 2 8.5 8.15
No : 1 & 2 (1:1,v/v) 7.05 6.55
Table 6.2.3.7.1 Comparative data obtained with control serums
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Fig. 5.2.3.7.1 Plots of data obtained by the immobilised 
uricase method and a soluble uricase method.
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6.3 Discussion
The use of uricase immobilised to nylon tube in the 
automated analysis of urate in serum was demonstrated.
Linear calibration plots of standard solutions of urate
(range of 2 - 20 mg urate.100ml”^) could be obtained using
l-2m immobilised uricase. The sensitivity of the method
was enhanced by using dichlorohydroxyl benzoyl sulphonate
as a chromogen in the colour-forming peroxidase reaction. The
increased sensitivity enabled the use of the immobilised enzyme
tube in the Technicon AAl AutoAnalyser without any modification 
to the analytical hardware, for determining the range of urate
found in serum.
Operational and storage stability studies showed the feasibility 
of using the immobilised uricase in routine analysis of urate in 
clinical laboratories. Linearity of calibration plots could be 
maintained up to 14 days when the immobilised enzyme tubes were 
exposed to room temperature, but the life could be prolonged if 
the enzyme tubes were stored at 4®, a normal requirement for most 
soluble enzymes and analytical reagents.
The precision of the method presented was high and comparable 
to many chemical and enzymatic methods (23,38). Depending on 
the degree of precision required, a sampling rate of 40 or 
GOh'l could be adopted.
Recovery studies showed that using protein-free standard
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solutions, the recovery of added urate to known urate samples 
was virtually 100%. On the other hand, the recovery of urate 
was less than 100% when the calibration was carried out with 
standard solutions of urate containing 7% albumin. Protein 
binding of urate has been pointed as the cause of reduced dialysis 
of urate across dialysis membrane, resulting in slight depression 
in urate values (about 5%)(34). Haeckel (36) also showed that 
protein was required in standard solutions for higher recoveries 
of added urate, but samples were not subject to dialysis.
There seemed to be no dialysis effect in these studies, but 
there was an apparent increase in the gradient of the calibration 
plot when protein-containing standard solutions were assayed.
It was observed in the interference studies, that albumin 
actually caused a slight elevation in the urate levels. Protein 
may cause greater sample to sample interactions which may cause 
increased readings.
Ascorbate has inhibitory effect on uricase (57), and enzymatic 
determination of urate can be affected by high concentration of 
ascorbate. However, the interference effect may have been on 
the colour-forming reactions. Cysteine and glutathione have 
not been shown to be inhibitory to uricase, so their effects would 
be on the peroxidase catalysed reactions. Fortunately, possibly 
due to a binding effect, the interference of cysteine and glutathione 
could be eliminated. In the case of ascorbate the interference 
was reduced in the presence of protein and as the normal level of 
ascorbate in serum is low (less than 2 mg.lOOml”^  , the effect
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would be minimal.
Sample interaction was low and as expected lower with 
the lower sampling rate. Variations in the carry-over coefficients 
may be due to the cleanliness of the flow system (pumping lines, 
glass connections and dialysis membrane). In any case the 
carry-over coefficients were less than 5%.
The presence of NaCl in the buffer was necessary for 
efficient dialysis or urate and minimisation of sample inter­
actions. Increasing salt concentration, however, did not seem 
to affect (decrease) the sample interaction, a factor which may 
be attributed to the absence of charges on the support (of the 
immobilised enzyme derivative). Slight suppression of the 
sensitivity with high salt concentration may be due to the 
"salting out" of oxygen in the buffer solution (working buffer).
Detergent is generally essential in minimising sample 
interactions. However, it was found that there was no obvious 
effect in the concentration range of Triton XlOO studied. 
Nevertheless, there was the possibility of the washing effect of 
the detergent in long continuous operation. In the complete 
absence of Triton XlOO in the assay buffer, the dialysis of urate 
through the membrane may be affected, though this property was 
not consistently observed. The state of the dialysis membrane 
may be the cause for this variation.
The accuracy of this method was compared with that of a 
soluble uricase method. Statistical data indicated a positive
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correlation between the results from the two methods. The data 
showed a slight bias between the two methods with the soluble 
method showing about 0.3% lower values.
Lower values of urate were obtained when Wellcomtrol 
serums were assayed by the immobilised enzyme method. This 
was to be expected as the manufacturer’s data was obtained by 
the chemical chelation method (21).
Pilippusson at al. (106) developed an automated method for 
the determination of urate using small packed bed of uricase 
immobilised to nylon powders. The method could be used for 
estimating urate in the range of 0.01 - O.lraM (0.17 - 1.7 mg.100ml” )^ 
but no stability and performance data were given.
Dritschilo and Weibel (140) immobilised uricase to porous 
glass beads producing fairly stable enzyme derivatives, for use 
in the analysis of urate in biological fluids. The immobilised 
enzyme was used as a packed bed reactor incorporated into a 
specially designed analytical system. Linear calibration plots 
were obtained for concentration of urate up to l.OmM (17 mg.lOOral"^).
Uricase immobilised to the surfaces of microporous membrane 
was also used for analysis of urate (141). The method utilised 
centrifugation to force samples through the membrane and thus 
into contact with the enzyme. It was claimed to have good 
reproducibility and accuracy, but no stability data were presented.
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7. GENERAL DISCUSSION
Bioaffinity chromatography has been shown to be a very 
useful procedure for uricase purification, a single bioaffinity 
step resulting in approximately 80-fold purification of the 
enzyme.
While bioaffinity chromatography can, in theory, be 
applied to crude enzyme extracts, there are technical problems 
resulting in difficulties in separating the enzyme-bound 
affinity supports.
There was some degree of non-specific adsorption on the 
affinity support, which on accumulation could have masked the 
ligands and reduced the effectiveness for bioaffinity adsorption. 
The low specific activity enzyme extract may further promote 
non-specific adsorption. Non-specific binding (hydrophobic and 
electrostatic) may occur in bioaffinity process, either 
with the ligands, spacers or the supports (142) . Hjerten at al. 
(143) in fact utilised hydrophobic affinity chromatography 
techniques using alkyl and aryl derivatives of agarose, for 
separation of serum proteins, enzyme extracts and virus particles.
The use of hydrophilic spacer between the support and ligand 
may diminish or eliminate completely non-specific adsorption (144). 
Considering that there are many other strong uricase inhibitors 
(145,146) and support matrices, there are possibilities for 
producing different bioaffinity supports for uricase separation
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utilising the varied chemistry available for coupling ligands 
and supports {67-71).
General ligand bioaffinity chromatography support as 
developed by Mosbach et al. (147) should also be considered for 
enzymes of the purine biosynthetic and catabolic pathways.
Many of the enzymes catalyse substrates or are inhibited by 
compounds comprising the purine ring, and thus there is a 
possibility of producing a general bioaffinity support for these 
enzymes, utilising this property.
In summary, the use of high specific activity enzyme 
extracts from bacterial or fungal sources may necessitate fewer 
purification steps.
Purified uricase has been successfully immobilised onto 
nylon with sufficient activity and stability for its use in the 
enzymatic analysis of urate, in place of its soluble counterpart. 
The use of bioaffinity chromatography may be useful in the 
production of large quantity of pure uricase, but it is obvious 
that the use of enzyme in the immobilised form should make 
considerable economies in the amount of enzyme used per analysis. 
It is ironic that, in the development of the analytical system, 
substrate retardation by the immobilised enzyme drivative was 
not desirable during analysis (to eliminate sample interaction), 
whereas this retarding effect [viz. enzyme retardation by 
immobilised substrate (or analogue)] was essential for protein 
separation (in bioaffinity technique).
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The analytical method presented necessitated the use of 
soluble peroxidase (POD) in the colour forming reactions.
Primary investigations on the immobilisation of POD onto nylon 
tube showed that the enzyme derivative was operationally unstable 
(148). A fully enzymatic method linking immobilised uricase to 
immobilised catalase and alcohol or aldehyde dehydrogenase may 
be possible as these enzymes have been immobilised to nylon tube 
(92,149). Direct detection of oxygen consumption may also be 
adopted employing a flow through oxygen electrode system (90).
There is every possibility that uricase immobilised to 
nylon tube can be incorporated into other existing analytical 
hardwares with or without prior modification to these hardwares. 
Glucose oxidase immobilised to nylon tube has been incorporated 
into the Technicon All AutoAnalyser successfully (150).
Leon et al. (151) used tabular enzyme reactors on the Technicon 
'SMAC' High Speed Analyser for the analysis of enzyme substrates 
with promising results.
Uricase is located strictly in the peroxisomes (52) and 
this distributive specificity is advantageous in the use of this 
enzyme as a marker for studying the mechanism of biogenesis, 
turnover and physiological role of these organelles. The 
availability of highly purified uricase is essential for the 
molecular enzymology studies of uricase. Immobilised uricase 
may provide more information towards the catalytic and molecular 
properties of uricase. Even the support-ligand complex can be.
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used as a tool for mechanistic studies of a particular enzyme (152) ,
The availability of highly purified uricase and its immobilised 
derivatives may prove useful in the therapeutic treatment of 
hyperuricaemic diseases, and the low cost factor in using 
immobilised uricase in analytical operation may enable monitoring 
of these diseases to be carried out more widely and economically.
The studies of immobilised enzymes may ultimately enable 
man to harness these biological catalysts for use in rectifying 
the errors of nature and in man-made industries, incorporating 
all the conditions necessary for high efficiency functioning.
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